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糖尿病の骨格筋における 
in vivo カルシウム調節機構 
 
江島 弘晃 
 
和文概要 
 
 骨格筋の形態や機能特性は，筋細胞内のカルシウムイオン恒常性が関係している．本研究は，
骨格筋の脆弱性を併発する糖尿病動物モデルを用いて，骨格筋のカルシウム恒常性調節機構を in 
vivo バイオイメージングによって検証した．その結果，糖尿病動物モデルは筋収縮によって細胞
質内にカルシウムイオンが蓄積しやすい現象を見出した. そして，その要因を検討するため，カ
ルシウムイオンを筋線維に直接インジェクションする手法を用いたところ，糖尿病動物モデルは
カルシウム放出−取込能力が低下することを明らかにした．このようなカルシウム処理機構の障害
は速筋と遅筋線維において観察されるが，その影響は速筋線維において顕著であることを示した．
本研究は，糖尿病が誘発する骨格筋の脆弱性がカルシウムイオン恒常性の低下と関連することを
in vivo バイオイメージングによって証明した． 
 
 
 
 
 
 
IN VIVO CALCIUN REGULATION 
IN DIABETIC SKELETAL MUSCLE 
 
Hiroaki ESHIMA 
 
Abstract 
 
The morphological and functional property in the skeletal muscle is associated with 
intracellular Ca
2+
 ([Ca
2+
]i) homeostasis.  In this thesis, [Ca
2+
]i homeostatic control 
mechanism was investigated by in vivo bioimaging on animal model of diabetes mellitus to 
associate with fragility of the skeletal muscle.  As a result, the diabetic animal model found 
the phenomenon that Ca
2+
 readily accumulated in cytoplasm by muscle contractions.  This 
study developed Ca
2+
 injection technique to muscle fiber to clarify mechanism of the 
dysfunction of [Ca
2+
]i homeostasis.  These studies model demonstrated that the Ca
2+
 
release-uptake system was impaired in the diabetes animals.  In addition, this study 
confirmed that the depression of [Ca
2+
]i homeostasis occurred in fast and slow muscle in 
diabetes.  This study evidenced that fragility of diabetic skeletal muscle was associated with 
depression of the [Ca
2+
]i homeostasis by an in vivo bioimaging. 
 
 
 
 
 
 
 
i 
 
 
 
Contents 
 
1. Introduction                          ・・・1 
1.1 Introduction                              ・・・1 
1.2 Background                                                           ・・・5 
1.2.1 Intracellular Ca2+ after muscle contraction and muscle fatigue in healthy  
skeletal muscle  ・・・5 
1.2.2 Muscle atrophy and functional properties in diabetes  ・・・9 
1.2.3 Alteration of muscle Ca2+ handling as a mechanism for dysfunction in 
diabetes                                                       ・・・13 
1.3 Purpose and Approaches of Thesis                                       ・・・19 
 
2. Intracellular Ca2+ dynamics following muscle contraction in diabetic skeletal 
muscle                                                          ・・・23 
2.1 Introduction                                                           ・・・23 
2.2 Methods                                                              ・・・25 
2.2.1 Animals                                                       ・・・25 
2.2.2 Muscle preparation                                             ・・・25 
2.2.3 Image analysis                                                ・・・26 
2.2.4 Experimental protocol                                         ・・・27 
2.2.5 Force measurement                                            ・・・28 
2.2.6 Statistical analysis                                             ・・・28 
2.3 Results                                                                ・・・29 
2.4 Discussion                                                             ・・・35 
2.5 Summary                                                             ・・・37 
 
3. Intracellular Ca2+ uptake dynamics in diabetic skeletal muscle  ・・・38 
3.1 Introduction                                                           ・・・38 
ii 
 
3.2 Methods                                                               ・・・40 
3.2.1 Experimental protocol                                          ・・・40 
3.2.2 Statistical analysis                                             ・・・40 
3.3 Results                                                                ・・・44 
3.4 Discussion                                                             ・・・47 
3.5 Summary                                                              ・・・49 
 
4. Evaluation of the factors associated with intracellular Ca2+ handling on 
diabetic skeletal muscle                                           ・・・50 
4.1 Introduction                                                           ・・・51 
4.2 Methods                                                               ・・・52 
4.2.1 Histology                                                      ・・・52 
4.2.2 Western blot analysis                                           ・・・53 
4.2.3 Statistical analysis                                             ・・・54 
4.3 Results                                                                ・・・55 
4.4 Discussion                                                             ・・・60 
4.5 Summary                                                              ・・・63 
 
5. Effect of muscle fiber type on intracellular Ca2+ dynamics of diabetes ・・・64 
5.1 Introduction                                                           ・・・64 
5.2 Methods                                                               ・・・67 
5.2.1 Muscle preparation                                             ・・・67 
5.2.2 Intracellular Ca2+ measurement                                 ・・・67 
5.2.3 Microvascular PO2 measurement                                ・・・68 
5.2.4 Stimulation                                                    ・・・69 
5.2.5 Histology                                                      ・・・70 
5.2.6 Western blot analysis                                       ・・・71 
5.2.7 Statistical analysis                                             ・・・71 
5.3 Results                                                                ・・・72 
5.4 Discussion                                                             ・・・85 
iii 
 
5.5 Summary                                                              ・・・90 
 
6. Discussion                                                       ・・・91 
6.1 Discussion                                                             ・・・91 
 
Acknowledgment                                                               ・・・94 
 
References                                                                     ・・・95 
 
List of Publications Related to the Thesis                                         ・・・111 
 
  
iv 
 
 
 
Abbreviation and note 
 
ABC  avidin biotinylated enzyme complex, アビジン ビオチン標識酵素複合体 
ADP   adenosine diphosphate, アデノシン二リン酸 
AP    action potential, 活動電位 
ATP    adenosine triphosphate, アデノシン三リン酸 
BCA  bicinchoninic acid, ビシンコニン酸 
Ca2+    calcium ion, カルシウムイオン 
[Ca2+]i   intracellular Ca2+ concentration, 細胞内カルシウムイオン濃度 
CaCl2  calcium chloride, 塩化カルシウム 
CANP  calcium activated neutral proteinase, カルシウム依存性中性プロテアーゼ 
CICR   calcium-induced calcium release, カルシウム誘発性カルシウム放出 
CO2  carbon dioxide, 二酸化炭素 
Ca-Pi  calcium phosphate, カルシウム無機リン酸 
CSA    cross sectional area, 断面積 
CSD    cross sectional diameter, 断面直径 
⊿  delta, 変化量 
DAB  3,3'-diaminobenzidine, ジアミノベンジジン 
DHPR   dihydropyridine receptor, ジヒドロピリジン受容体 
DIA   diabetes mellitus, 糖尿病 
DMSO  dimethyl sulfoxide, ジメチルスルホキシド 
EDL    extensor digitorum longus, 長趾伸筋 
EDTA  ethylenediaminetetraacetic acid, エチレンジアミン四酢酸 
EGTA  ethylene glycol tetraacetic acid, グリコールエーテルジアミン四酢酸 
Gas    gastrocnemius, 腓腹筋 
gm  resting membrane conductance, 安静時膜電位伝導力 
H+    proton, 水素イオン 
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HE  hematoxylin and eosin, ヘマトキシリン&エオジン 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, ヘペス 
HRT    half-relaxation time, 半弛緩時間 
KCl  potassium chloride, 塩化カリウム 
KHB  krebs-henseleit buffer, クレブス緩衝液 
MgCl2  magnesium chloride, 塩化マグネシウム 
MgSO4  magnesium sulfate, 硫酸マグネシウム 
MHC   myosin heavy chain, ミオシン重鎖 
MRR   maximal relaxation rate, 最大弛緩率（速度） 
MW    muscle weight, 筋重量 
N2  nitrogen, 窒素 
NaCl   sodium chloride, 塩化ナトリウム 
NaF  sodium fluoride, フッ化ナトリウム 
NaHCO3  sodium hydrogen carbonate, 炭酸水素ナトリウム 
NaOH  sodium hydroxide, 水酸化ナトリウム 
NaVO4  sodium orthovanadate, オルトバナジウム酸ナトリウム 
O2  oxygen, 酸素 
Pi  inorganic phosphorus, 無機リン酸 
PBS  phosphate buffered saline, リン酸緩衝生理食塩水 
PmvO2  microvascular O2 pressure, 微小血管（毛細血管）酸素分圧 
Q ˙O2  oxygen quotient, 酸素消費 
RMP    resting membrane potentials, 安静時膜電位 
ROS    reactive oxygen species, 活性酸素種 
RyR    ryanodine receptor, リアノジン受容体 
SAC   stretch-activated channels, 機械受容チャネル 
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SR     sarcoplasmic reticulum, 筋小胞体 
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Chapter 1 
Introduction 
 
1.1 Introduction 
 
Diabetes mellitus is defined as a group of metabolic diseases that are associated with the 
presence of hyperglycemic state due to impairments in insulin function by pancreatic β-cells. 
Also, proximately 150 million people worldwide suffer from diabetes (Grundy et al., 1999). In 
Japan, it is estimated that about 20 million people are currently afflicted with diabetes 
(Ministry of Health, Labour, and Welfare, Japan). Diabetes mellitus can result from insulin 
deficiency or resistance and is characterized by a variety of metabolic disturbances including 
reduced cellular glucose uptake, decreased fatty acid oxidation, and mitochondrial 
dysfunction. In addition, dysfunction of insulin signaling induces muscle atrophy, which leads 
to reduced functional capacity and muscle weakness. In diabetes mellitus, there is a failure to 
maintain healthy muscle termed diabetic myopathy (Andersen et al., 1996; Algenstaedt et al., 
1997; Andersen et al., 1997; Andersen et al., 2004; Andersen et al., 2005; D'Souza et al., 2013). 
Not only is muscle mass decreased but the muscle fibers are more fragile and fatigable and 
display abnormal calcium (Ca2+) regulation (i.e., impaired homeostasis) (Cotter et al., 1989; 
Steele & Duke, 2003; Sanchez et al., 2005; Aughsteen et al., 2006; Allen et al., 2008a). 
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Ca2+ is a highly versatile intracellular signal in a living tissue. To achieve this versatility, 
the Ca2+ signaling system operates in many different ways to regulate cellular processes that 
function over a wide dynamic range (Berridge et al., 2003) (Figure 1.1). In skeletal muscle, 
Ca2+ signaling plays a fundamental role in many cellular processes including growth and 
development, metabolism, and regulation of gene expression (Chin & Allen, 1996; Allen et al., 
2008a, b). In particular, there is a transient elevation of intracellular Ca2+ concentration 
([Ca2+]i) that it is requisite for triggering muscle contraction and thus active tension 
development. Following contraction and relaxes as Ca2+ is rapidly taken up by the 
sarcoplasmic reticulum (SR) and other intracellular organelles (on see Figure 1.1) and [Ca2+]i 
decreases almost immediately. It is generally accepted that Ca2+ handling (i.e., Ca2+-release 
and reuptake) by the sarcoplasmic reticulum (SR) is a crucial element in the control of 
excitation–contraction coupling.  
Interestingly, the [Ca2+]i dysregulation of diabetic muscle occurs in the presence of an 
enhanced SR function, at lease in vitro (Ganguly et al., 1986; Ganguly et al., 1987; Taira et al., 
1988; Taira et al., 1991). To date, the dysregulation of [Ca2+]i and SR function in diabetes has 
been investigated predominantly in vitro where, by necessity, the circulation is not intact. 
Thus, these muscles/muscle fibers are subjected to non-physiologic oxygen conditions 
including hyperoxia. Given that muscle contractile energetics (Behnke et al., 2003; 
McDonough et al., 2005) and SR Ca2+ regulation are substantially oxygen dependent (oxygen 
flux and intramyocyte oxygen pressure) it is uncertain to what degree the experimental 
results reflect the in vitro conditions versus the diabetic myopathy itself. It is pertinent that, 
in diabetes, microcirculatory control is grossly deranged with respect to capillary 
hemodynamics (Padilla et al., 2006) and microvascular oxygenation profiles during 
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contractions in skeletal muscle (Padilla et al., 2007). In this thesis considers the impact of 
diabetes on the capacity of skeletal muscle to regulate [Ca2+]i following muscle contractions 
and, in particular, the relationship between muscle fatigue and elevated [Ca2+]i in a highly 
ecologically relevant circulation-intact environment. 
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Figure 1.1: Calcium-signalling dynamics and homeostasis. During the ‘on’ reactions, stimuli 
induce both the entry of external Ca2+ and the formation of second messengers that release 
internal Ca2+ that is stored within the endoplasmic/sarcoplasmic reticulum (ER/SR). Most of 
this Ca2+ (shown as red circles) is bound to buffers, whereas a small proportion binds to the 
effectors that activate various cellular processes that operate over a wide temporal spectrum. 
During the ‘off ’ reactions, Ca2+ leaves the effectors and buffers and is removed from the cell by 
various exchangers and pumps. (From Berridge et al, 2003) 
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1.2 Background 
1.2.1 Intracellular Ca2+ after muscle contraction and muscle fatigue 
in healthy skeletal muscle 
 
The contraction–relaxation cycle of myocytes is regulated by transient increases of 
cytosolic [Ca2+]i above the normal resting value (i.e., < 100 nM) (Armstrong et al., 1991) which 
in non-fatigued and non-damaged conditions is almost immediately re-established after the 
contraction. Indeed, the speed of muscle contraction and relaxation are critically dependent 
on effective SR Ca2+ handling. This process of muscle excitation–contraction coupling is 
initiated by sarcolemmal and transverse tubule depolarization that triggers Ca2+ release from 
the SR via the ryanodine receptor (RyR). RyR-mediated Ca2+ release is activated through 
charge-dependent conformational changes of the dihydropyridine receptor (DHPR) 
(Sorrentino, 1995; Endo, 2009). Subsequently, the SR Ca2+-ATPase (SERCA) performs the 
critical function of promoting muscle relaxation by sequestering Ca2+ from the cytoplasm at 
the expense of adenosine triphosphate (ATP) hydrolysis (Dux, 1993; MacLennan et al., 1997). 
In healthy single myocytes from rodent skeletal muscle moderate-intensity non-fatiguing 
tetanic contractions may produce no detectable increase in the resting [Ca2+]i whereas more 
intense and prolonged contraction protocols may elevate [Ca2+]i. Chin and Allen employed a 
specially-designed fatiguing bout of 100 Hz tetanic contractions which increased resting 
[Ca2+]i from 54 to 132 nM supporting a putative mechanistic linkage between elevated resting 
[Ca2+]i (Chin & Allen, 1996) and the fatigue process (Carroll et al., 1999; Gissel, 2000). Unlike 
the situation in cardiomyocytes, in skeletal muscle, the influx of extracellular Ca2+ across the 
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sarcolemma is not thought to contribute significantly to excitation–contraction coupling; at 
least not during acute activation. However, the long-term maintenance of [Ca2+]i homeostasis 
in skeletal muscle does require Ca2+ influx from the extracellular space, as documented 
recently for isolated mouse soleus muscles (Allen et al., 2008b). Under certain circumstances, 
however, an influx of Ca2+ may occur via stretch-activated channels (SAC) present in the 
myocyte sarcolemma (Sonobe et al., 2008; Sonobe et al., 2010). 
More recently, Kano and colleagues, developed an in vivo skeletal muscle (anesthetized 
rat spinotrapezius) preparation and real-time Ca2+-dependent fluorescence to demonstrate 
that, when the muscle and its vascular and neural supplies remained intact, resting myocyte 
[Ca2+]i increased following tetanic isometric contractions (Sonobe et al., 2008) (Figure 1. 2). 
Specifically, they found that the peak level of [Ca2+]i was increased by 1.2-fold after 10 sets 
(i.e., 500 contractions) of isometric contractions. Interestingly, after the same number of 
lengthening (stretch) contractions resting [Ca2+]i increased to a greater extent (i.e., 1.5-fold 
over pre-contraction levels). An effect that was intriguingly far less pronounced in female 
versus male rats (Sonobe et al., 2010). 
The two major potential sources of Ca2+ are the SR and the extracellular space. During 
tetanic contractions, Ca2+ originates exclusively from the SR whereas contractions with 
simultaneous mechanical stretch invoke participation of the SAC as well as the SR. It has 
also been shown that stretch-induced contractions lead to membrane tears, which may also 
allow substantial “extra” Ca2+ entry (McNeil & Khakee, 1992; Allen, 2004). Continuous high 
levels of [Ca2+]i after contractions with mechanical stretch lead to sarcomeric disruption and 
membrane damage and invoke muscle regeneration via apoptosis and necrosis. 
Muscle fatigue encompasses several aspects of muscle performance including  
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Figure 1.2: Schematic showing direct microscopic observation of spinotrapezius muscles and 
[Ca2+]i in vivo. Fluorescence images captured from the same area of muscle tissue.Ratio (R: 
F340/F380) image was converted and mean gray-scale value measured. This model facilitates 
direct measurements under physiological conditions that preserve vascular/microvascular 
and neural supplies. 
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maximum/peak isometric force, a reduction of shortening velocity and a slowing of relaxation. 
In 1963 Eberstain and Shadow simultaneously increased the SR Ca2+ release and force 
development in fatigued muscle fibers using caffeine. They proposed that the impairment of 
Ca2+ release from the SR constituted a key factor in fatigue development (Allen et al., 2008b). 
This concept is consistent with a wealth of subsequent evidence in whole muscles and 
individual muscle fibers showing that application of caffeine, to a muscle fatigued with 
repetitive tetanic stimulations, almost completely restores force development capacity by 
improving Ca2+ release from the SR to pre-fatigue levels (Allen & Westerblad, 1995). 
Matsunaga et al. demonstrated directly that the SR Ca2+-sequestering ability of rat muscle is 
impaired after in vivo high intensity exercise (maximal O2 uptake) (Matsunaga et al., 2003). 
Thus, it is generally accepted that limitations of SR Ca2+ handling (i.e., Ca2+ release and 
uptake) can represent an important component in the etiology of muscle fatigue. Furthermore, 
a reduction in maximal isometric force, indicative of fatigue, may be manifested as early as 
the second contraction in a series of tetani (Lannergren & Westerblad, 1991; Allen et al., 
2008a). 
Although the mechanisms underlying impaired SR Ca2+ regulatory function (i.e., Ca2+ 
release and reuptake) in fatigued skeletal muscle have not been completely elucidated, there 
is evidence that [Ca2+]i is impacted by intracellular metabolic perturbations (e.g., intracellular  
adenosine diphosphate (ADP), proton (H+), inorganic phosphorus (Pi) and reactive oxygen 
species (ROS)) (Favero, 1999; Steele & Duke, 2003; Allen et al., 2008a, b). The specific 
mechanism for this effect may involve Ca-Pi precipitation-induced reduction of the amount of 
available Ca2+ stored in SR (Fryer et al., 1995). Consistent with this observation, within 
mechanically skinned but excitation–contraction intact single rat fast-twitch myocytes, 
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elevated [Pi] (30 mM) reduces the action potential-induced SR Ca2+ release as effectively as 
almost total SR Ca2+ depletion (Dutka et al., 2005). In addition, Hogan and colleagues 
proposed that factors related to the energetic cost of cross-bridge cycling, possibly the 
accumulation of metabolites (particularly cytosolic H+ and possibly SR [Pi]) caused an 
inhibition of the Ca2+ pumping during fatiguing contractions in single Xenopus myocytes 
(Nogueira et al., 2013). Another feature of the response that supports participation of altered 
metabolite concentrations in the decreased SR-Ca2+-sequestering capacity is that, after high 
intensity exercise, SR-Ca2+-sequestering capacity progressively reverts to normal levels 
during recovery (Matsunaga et al., 2008). Thus the elevated resting [Ca2+]i may result from 
attenuation of SR Ca2+ uptake in addition to leak from the SR and/or possibly the 
extracellular space. It is pertinent that these mechanisms are not specific to mice and rats as 
the increased resting [Ca2+]i induced using a low frequency fatigue protocol in murine 
myocytes (Chin & Allen, 1996) is also present in isolated toad muscle (Rosser et al., 2009). 
 
1.2.2 Muscle atrophy and functional properties in diabetes 
 
Diabetes may induce a profound loss of muscle mass, muscle weakness, and impaired 
neural control. In rodent studies, pharmacologically-induced (streptozotocin or alloxan) type I 
diabetes mellitus results in impaired muscle force production, enhanced fatigability and 
increased muscle fragility (Grossie, 1982; Paulus & Grossie, 1983; Cotter et al., 1989; 
Medina-Sanchez et al., 1991; Sanchez et al., 2005; Aughsteen et al., 2006). Similarly, in 
humans diabetes is associated with chronic neuropathy which has been implicated in the 
decreased muscle mass and force production (Andersen et al., 1996; Andersen et al., 1997; 
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Andersen et al., 2004; Andersen et al., 2005). 
Impairment of function in diabetic skeletal muscle is fiber type specific (Table 1.1). For 
instance, fast-twitch/glycolytic myosin-heavy chain (MHC) type II fibers (the extensor 
digitorum longus; EDL or isolated fast twitch fibers) often have impaired force production 
whereas slow-twitch/oxidative/MHC type I fibers (soleus; SOL or slow-twitch fibers) are 
affected to a lesser extent or not at all (Cotter et al., 1989; Cameron et al., 1990; Cotter et al., 
1993; Stephenson et al., 1994; Lesniewski et al., 2003). However, the expression of muscular 
dysfunction in diabetic skeletal muscle is determined strongly by the specific chemical agent 
used for its induction or the precise genetic model as well as the duration and severity of the 
disease. For instance, decreased muscle fiber size and impaired force production are present 
in both fast and slow-twitch fibers in alloxan-induced diabetic rats (Paulus & Grossie, 1983). 
On the other hand, Lesniewski et al. reported that force production of slow-twitch fibers is 
unaffected in the streptozotocin (STZ)-diabetic mouse model. Within fast twitch muscle at 4 
weeks duration neural impairment and muscle dysfunction both contributed to a reduced 
force production whereas at 8 weeks dysfunction was wholly muscle-induced (Lesniewski et 
al., 2003). Whereas Krause et al. demonstrated atrophy in mouse fast-twitch muscle in Ins2 
Akita+/−mice (nonpharmacological genetic model of type I diabetes mellitus) mass-specific 
force was unaffected. Somewhat differently, STZ-induced diabetic mice displayed an increased 
mass-specific force coupled with a rise in half-relaxation times following contractions  
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(Krause et al., 2009). This latter finding is common across many investigations examining 
STZ-induced diabetes in rodents (Paulus & Grossie, 1983; McGuire & MacDermott, 1999; 
McGuire et al., 2001; Krause et al., 2009). 
Muscle fiber types may undergo transformation in diabetes. Using histological 
determination of EDL fiber type (fast-twitch fibers, MHC type II dominant muscle in healthy 
controls), diabetes increases the relative percentage of slow-twitch/oxidative (MHC type I, IIa) 
and decreases that of the fast-twitch/glycolytic (MHC type IIb) fibers (Klueber et al., 1989; 
Klueber & Feczko, 1994; Jerkovic et al., 2009). This phenomenon also occurs in obese Zucker 
rats where the proportion of oxidative muscle fibers was greater in the muscles from obese 
rats than in their lean counterparts (Benton et al., 2010). However, previous studies using 
skeletal muscle of type II diabetic animal models (i.e., Goto-Kakizaki rat or Otsuka 
Long-Evans Tokushima Fatty rat) (Yasuda et al., 2002; Yasuda et al., 2006) as well as human 
studies (He et al., 2001; Crowther et al., 2003; Oberbach et al., 2006; Fritzsche et al., 2008) 
demonstrated an increased relative percentage of fast-twitch/glycolytic muscle fibers and an 
accompanying upregulation of glycolytic enzymes. Hence, great caution must be exercised 
when trying to make broad statements regarding the impact of diabetes on the mechanistic 
bases for muscle dysfunction. 
 
1.2.3 Alteration of Ca2+ handling as a mechanism for muscle 
dysfunction in diabetes 
 
One putative mechanism for functional alterations in diabetic skeletal muscle relates to 
impairments of Ca2+ handling as maybe the case in many tissues (Levy et al., 1994). For 
instance, decreased SR Ca2+ transport and SR Ca2+ content have been detected in cardiac 
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muscle from animal diabetic models (Netticadan et al., 2001; Choi et al., 2002; Satoh & 
Kitada, 2003; Howarth et al., 2011). However, certain aspects of the Ca2+ handling system of 
skeletal muscle may not necessarily be compromised in diabetes; there being apparently 
contradictory findings of both improved function and dysfunction in diabetic skeletal muscle 
as cataloged briefly below and in Table 1.2. 
 
Dysfunctional Ca2+ handling in diabetic skeletal muscle: 
1. Absorption spectrophotometry-assays indicate increased [Ca2+]i (Nakagawa et al., 1989; 
Zemel et al., 1990). 
2. There is elevated calcium-activated neutral proteinase (CNAP) (Kobayashi et al., 1989). 
3. SR Ca2+ uptake activity decreases in STZ-induced diabetic rats (Eibschutz et al., 1984). 
4. SR Ca2+-ATPase protein levels decline in soleus (slow-twitch fibers, MHC type I dominant 
muscle) of STZ diabetic rats (Racz et al., 2009). 
5. The association of insulin receptor substrates (IRS) with SR Ca2+-ATPase protein is 
reduced in STZ-diabetic rats (Algenstaedt et al., 1997). 
6. In diaphragm muscle, there are decreased Ca2+ transients and modified resting 
membrane potential and conductance in diabetic mice (Kimura et al., 1988; Kimura & 
Kimura, 1990; Kimura et al., 1995). 
7. Ca2+-dependent proteolysis activity is increased in STZ-diabetic rats (Baviera et al., 2007; 
Baviera et al., 2008). 
8. Expression of calcineurin, a Ca2+-dependent phosphatase, was suppressed in 
STZ-diabetic rats (Roberts-Wilson et al., 2010). 
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    Collectively, these data suggest that [Ca2+]i homeostasis is impaired in diabetic skeletal 
muscle. 
 
Improved Ca2+ handling in diabetic skeletal muscle: 
1. SR Ca2+ transport activity increases during the development of diabetes (Ganguly et al., 
1986; Taira et al., 1991). 
2. Fast-twitch fibers evidence increased Ca2+ uptake whilst slow-twitch fibers and heart 
muscle are not different or decreased in STZ-diabetic rats (Ganguly et al., 1987). 
3. Calmodulin levels are elevated (Morley et al., 1982) and there is an increased 
phospholipid membrane Ca2+ permeability that both potentially act to increase 
Ca2+-ATPase activity in diabetic rats (Taira et al., 1988). 
4. Sarcolemmal Ca2+ channel numbers increase (Lee & Dhalla, 1992; Ogawa et al., 1995). 
5. Calsequestrin, a high-capacity Ca2+-binding protein, is increased in STZ-diabetic rats 
(Howarth et al., 2002). 
 
Collectively these data suggest that certain aspects of the Ca2+ handling system are 
down-regulated, whilst others are up-regulated in diabetic skeletal muscle. Features of the 
model system under investigation as well as the degree and duration of hyperglycemia may be 
crucial to consider in these adaptive responses. It is also pertinent that Ca2+-ATPase activity 
and Ca2+ uptake may be higher among people with type I diabetes compared with matched 
non-diabetic controls (Harmer et al., 2014). At present, it is unclear to what degree the 
disparity highlighted above is attributable to investigation of ex vivo rather than in vivo 
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tissues and analyses. What may be particularly insightful with respect to resolving the 
mechanistic bases for Ca2+ handling alterations in diabetic skeletal muscle is the utilization of 
a relevant in vivo model that permits tight control over the experimental environment. 
The majority of the investigations cited above have used isolated single or skinned 
muscle fibers (i.e., in vitro studies). Thus, the insights they provide must be tempered by the 
inherent limitations in relating the data obtained to in vivo physiological conditions. For 
instance, as distinct from in vivo conditions: (1) Single fibers do not survive well at 
physiological temperature and are often maintained in a hypothermic environment. (2) There 
is no blood circulation which negates normal O2 and substrate supply and metabolite removal. 
(3) Non-physiologic high O2 environments are often created that change energetic and redox 
regulation as well as mitochondrial and contractile function. (4) There are no interactions 
among different muscle fiber types. (5) Neural modulation is abolished. (6) The intracellular 
ion dynamics that may affect muscle fatigue are impacted. All of these impositions will act to 
disrupt the in vivo physiology via the perturbations listed above in addition to a host of 
intracellular signaling mechanisms. 
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1.3 Purpose and Approaches of Thesis 
 
In this thesis, attention is focused on the relationship between the dysfunctional 
contractile activity, muscle fatigue and impaired [Ca2+]i regulation in a highly ecologically 
relevant circulation-intact environment in diabetic skeletal muscle. However, the mechanism 
of [Ca2+]i dysregulation in diabetic skeletal muscle cannot be fully elucidated. Thus, the 
objectives are listed as follows: 
 
Effect of diabetes on intracellular Ca2+ accumulation following isometric 
contraction 
The contraction-relaxation cycle of myocytes is regulated by changes of [Ca2+]i. Resting 
myocytes maintain [Ca2+]i under ~0.1 µM (Armstrong et al., 1991). When myocytes contract, 
there is a transient elevation of [Ca2+]i that helps triggers muscle contraction. In nonfatigued 
and nondamaged myocytes, as the muscle relaxes after contraction, [Ca2+]i decreases 
immediately. However, long-repeated contractions induce myocyte fatigue (reduction of 
tetanic force), myocyte damage, and prolonged elevation of [Ca2+]i after contraction(s) (Gissel, 
2000; Stary & Hogan, 2000). Furthermore, the effects of diabetes on [Ca2+]i accumulation 
kinetics following repeated muscle contractions are unclear. 
The first purpose of thesis is to measure the [Ca2+]i profiles in diabetic skeletal muscle 
following muscle contractions, under in vivo condition. 
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Intracellular Ca2+ uptake dynamics in diabetic skeletal muscle 
In the [Ca2+]i kinetics of diabetic skeletal muscle, interestingly, it has been reported that 
the [Ca2+]i dysregulation occurs in the presence of an enhanced SR function, at lease in vitro 
(Ganguly et al., 1986; Ganguly et al., 1987; Taira et al., 1988; Taira et al., 1991). However, a 
direct measurement of Ca2+ handling in diabetic in vivo models is unknown. 
The second purpose of thesis is to elucidate the profiles of Ca2+ uptake in diabetic skeletal 
muscle, using a direct Ca2+ injections in vivo model. 
 
Evaluation of the factors associated with intracellular Ca2+ handling on diabetic 
skeletal muscle  
Maintenance of Ca2+ homeostasis is controlled by SR and mitochondria. In skeletal 
muscle, Ca2+ regulatory (Ca2+ release and uptake) protein expression of SR in diabetic animal 
models is up or down-regulated. In addition, previous studies reported that diabetes induced 
a profound decrease mitochondrial oxidative capacity in hindlimb locomotory muscle (Klueber 
& Feczko, 1994; Gordon et al., 2010). Thus, the third purpose of thesis is to measure the SR 
Ca2+ regulatory protein expression levels and mitochondrial oxidative enzyme activity of 
spinotrapezius muscle in diabetes.  
 
Effect of muscle fiber type on intracellular Ca2+ kinetics of diabetes 
    The fourth purpose of thesis is to measure the effect of muscle fiber type on [Ca2+]i 
kinetics of diabetic skeletal muscle. In particular, the chapter focused on the buffering of 
[Ca2+]i following tetanic contraction in vivo in diabetic skeletal muscle (fast versus slow-twitch 
fibers). 
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Approaches 
In the previous studies, all investigations of [Ca2+]i have been performed under in vitro 
conditions. In previous studies, bioimaging techniques can visualize intracellular ions directly 
(Tsien et al., 1982; Tsien et al., 1985; Cobbold & Rink, 1987; Rudolf et al., 2006), and, whereas 
measurements of [Ca2+]i are potentially feasible under intravital conditions routinely used for 
microcirculation studies, to date, because skeletal muscle was considered to be too thick for 
microscopy, most studies of [Ca2+]i have used isolated or cultured single myocytes. 
To achieve the first and second purposes, this study uses the bioimaging technique 
methods and the spinotrapezius which is sufficiently thin to permit transmission light 
microscopy. Spinotrapezius muscle is composed of all three major mammalian muscle fiber 
types (Delp & Duan, 1996), and has an oxidative capacity similar to that of the human 
quadriceps (Leek et al., 2001). In addition, the third purpose measure the SR Ca2+ regulatory 
protein expression levels and mitochondrial oxidative enzyme activity of spinotrapezius 
muscle in diabetes. 
The experiment technique to achieve the fourth purpose intended for hindlimb muscle. In 
hindlimb muscle, specialized in fast and slow-twitch fiber types is excised. So, 
calcium-handling properties according to the muscle fiber type may be highlighted. However, 
depression of the resolution by the thickness of the hindlimb muscle was main technical 
problem. Thus, the fourth purpose tried to examine the Ca2+ regulation in vivo in hindlimb 
muscle in diabetes. 
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Chapter 2 
Intracellular Ca2+ dynamics following muscle 
contraction in diabetic skeletal muscle 
 
2.1 Introduction 
 
In diabetes mellitus, force production in skeletal muscle is impaired, while fatigability 
and muscle fragility are increased (Cotter et al., 1989; Andersen et al., 2005; Sanchez et al., 
2005; Aughsteen et al., 2006). Maintenance of Ca2+ homeostasis across repeated muscle 
contractions is requisite for optimal contractile function (Brini & Carafoli, 2009). It is 
generally accepted that limitations of SR Ca2+ handling (i.e., Ca2+ release-uptake) can 
represent an important component in the etiology of muscle fatigue (Favero, 1999; Steele & 
Duke, 2003; Allen et al., 2008a, b). Although those mechanisms underlying impaired SR Ca2+ 
regulatory functions in fatigued skeletal muscle have not been completely elucidated, there is 
evidence that metabolic perturbations (e.g., ADP, H+, Pi, reactive oxygen species) within the 
cell affect [Ca2+]i (Fryer et al., 1995; Dutka et al., 2005). The increment in resting [Ca2+]i 
during muscle fatigue has been observed in isolated toad (Rosser et al., 2009) and mouse 
single muscle fiber preparations using a low frequency fatigue protocol (Chin & Allen, 1996). 
More recently, Sonobe et al. demonstrated that the resting level of [Ca2+]i increased, following 
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tetanic contractions, using a novel in vivo skeletal muscle (anesthetized rat spinotrapezius) 
model and measuring Ca2+-dependent fluorescence intensity in real time. Following 
electrically-evoked contractions, resting [Ca2+]i increased by 1.2-fold over pre-contraction 
levels (Sonobe et al., 2008; Sonobe et al., 2010). [Ca2+]i accumulation may result from 
attenuation of SR Ca2+ uptake and/or leak from the SR and/or extracellular space. However, 
the effects of continuous muscle contractions on [Ca2+]i accumulation kinetics are unclear in 
diabetes. Thus, this study hypothesized that, following repeated bouts of muscle contractions, 
the rise in [Ca2+]i evident in healthy rats would be magnified in skeletal muscles of diabetic 
rats, under the in vivo environment. 
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2.2 Methods 
2.2.1 Animals 
 
Male Wistar rats (10 wk of age; Japan SLC, Shizuoka, Japan) were used in this study. 
Rats were maintained on a 12:12-h light-dark cycle and received food and water ad libitum. 
Rats were divided into two groups: healthy control (CONT) and diabetic (DIA) rats. DIA rats 
were anesthetized using isoflurane and given intraperitoneal injection of 45 mg/kg body 
weight of streptozotocin (STZ; S0130, Sigma-Aldrich St. Louis, MO) prepared fresh in saline 
solution. CONT animals were injected with the saline solution. Urine glucose levels of rats 
were measured (New Uriesu Ga, Terumo, Japan) 2 days after STZ injection with the onset of 
diabetes raising glucose concentrations above 500 mg/dl. These measurements of urine 
glucose were continued each week for 4 wk. At experiment completion, blood was collected 
from a tail vein puncture to confirm that the blood glucose level exceeded 300 mg/dl. All 
experiments were conducted under the guidelines established by the Physiological Society of 
Japan and were approved by the University of Electro-Communications Institutional Animal 
Care and Use Committee. Rats were anesthetized using pentobarbital sodium (60 mg/kg ip), 
and supplemental doses of anesthesia were administered as needed. At the end of 
experimental protocols, animals were killed by pentobarbital sodium overdose. 
 
2.2.2 Muscle preparation 
 
All experimental techniques, including the spinotrapezius muscle preparation, were 
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performed, as described previously (Sonobe et al., 2008). The right spinotrapezius muscle was 
carefully accessed through an ~4-cm-long midline incision through the skin, starting at the 
lower cervical level and extending caudally to the upper lumbar vertebral level. 
Exteriorization was performed with as little disruption as possible to minimize tissue damage. 
With the exception of the distal feed artery, all of the vascular and nervous connections 
remained intact as the caudal perimeter of the muscle was dissected free of connective tissue 
attachments. The exposed spinotrapezius muscle was attached to a thin-wire horseshoe 
around the caudal periphery by five to six equidistant sutures placed around the caudal 
perimeter. For the contraction protocols, electrodes were placed on the dorsal spinotrapezius 
surface along the caudal periphery, facilitating whole muscle contractions. The exposed 
muscle tissue was kept moist by superfusing with warmed Krebs-Henseleit buffer (KHB; 132 
mM NaCl, 4.7 mM KCl, 21.8 mM NaHCO3, 2 mM MgSO4, and 2 mM CaCl2) equilibrated with 
95% N2-5% CO2 and adjusted to pH 7.4, at 37°C. The fluorescent Ca2+ indicator Fura-2 AM 
(Dojindo Laboratories, Kumamoto, Japan) was dissolved at 5 mM in DMSO and Pluronic 
F-127 and dispersed into KHB solution at a final concentration of 20 µM. The muscles were 
incubated in Fura-2 AM/KHB solution for 30–60 min on a 37°C hotplate. After incubation, 
muscles were rinsed with dye-free KHB solution to remove nonloaded Fura-2. 
 
2.2.3 Image analysis 
 
The spinotrapezius muscles loaded with Fura-2 AM were mounted on the 37°C glass 
hotplate (Kitazato Supply, Shizuoka, Japan) and observed by fluorescence microscopy using a 
10× objective lens (0.30 numerical aperture; Nikon, Tokyo, Japan). After ensuring that the 
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spinotrapezius muscle was not grossly damaged and supported robust capillary blood flow, a 
sampling area (~880 × 663 µm) was selected using branching vessels as landmarks, and 
bright-field images were captured. Thereafter, 340-nm and 380-nm wavelength excitation 
light was delivered using a Xenon lamp equipped with appropriate fluorescent filters, and 
pairs of fluorescence images were captured through the 510-nm emission wavelength filter for 
ratiometry. 
 
2.2.4 Experimental protocol 
 
Spinotrapezius muscles from CONT and DIA rats were stimulated to contract, as 
described in detail previously (Sonobe et al., 2008). The time course of [Ca2+]i change was 
observed after each of 10 discrete sets of isometric tetanic muscle contractions. Each set 
consisted of the muscle being stimulated tetanically at resting spinotrapezius sarcomere 
length (100 Hz, 5–8 V, stimulus duration 700 ms, 2.6- to 2.8-µm sarcomere length) every 3 s 
for 2.5 min (i.e., 50 contractions). Pairs of fluorescence images were captured precontraction, 
and after each set of contractions, as well as at the end of the 5-min between-set recovery 
(immediately before initiation of the subsequent set of contractions). Images were captured by 
a CCD digital camera (DP70; Olympus, Tokyo, Japan) using image-capture software (DP 
Control; Olympus, Japan). After selecting an appropriate region of interest, which included 
multiple muscle fibers, the spinotrapezius fluorescence was observed. Images were converted 
to 340/380 ratio (F340/F380; R) images by ImageJ software [National Institutes of Health 
(NIH), Bethesda, MD], and the ratio image data, indicating [Ca2+]i levels, were averaged over 
the whole area sampled. The fluorescence intensity of serial ratio images was normalized to 
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the starting point (i.e., precondition, R0) of each experiment (R/R0). 
 
2.2.5 Force measurement 
 
The wire horseshoe attached to the spinotrapezius muscle was connected by fine wire to a 
strain gauge. Torque was monitored by a computer using Mac Lab/8s (AD Instruments, 
Colorado Springs, CO) via a strain gauge-linked motor device (0–10 mN/m, full-scale 
deflection, model no. RU-72; NEC Medical Systems, Tokyo, Japan) during all contraction 
protocols. The muscle force during electrical stimulation (700 ms) was resolved as active force 
(isometric phase, 0–200 ms). Among the 10 sets of 50 contractions, the first 5 and last 5 
contractions of set numbers 1, 5, and 10 were averaged and plotted graphically as an index of 
fatigue. 
 
2.2.6 Statistical analysis 
 
Values are expressed as means ± SE. Statistical analyses were performed in Prism 
version 4.0 (GraphPad Software, San Diego, CA). Two-way repeated-measures ANOVA and 
Bonferroni post hoc test were used for group differences in [Ca2+]i levels. One-way 
repeated-measures ANOVA and Bonferroni post hoc test were used for relative force 
comparison in repeated bouts of muscle contractions. T-tests were used for blood glucose 
levels, histological data, and relative protein levels. The level of significance was set at P < 
0.05. 
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2.3 Results 
 
Blood glucose concentration was 98.6 ± 6.1 (range of 89 to 128) and 393.6 ± 35.3 (range of 
317 to 600) mg/dl in CONT and DIA, respectively (P < 0.01; Table 2.1). DIA rats evidenced a 
significant decrease in body weight at 4 wk post-STZ injection (Table 2.1). 
Absolute Fura-2 ratios (i.e., 340 nm/ 380 nm fluorescence intensity) were no significant 
differences in before the start of experiments in both CONT and DIA (Figure 2.1). After 
repeated bouts of muscle contractions, Fura-2 ratios were increased in both CONT and DIA 
(Figure 2.2). [Ca2+]i became significantly elevated above baseline only after six sets of 
contractions in CONT (Figure 2.3). In marked contrast, significant [Ca2+]i accumulation in 
DIA occurred following the very first set of contractions. After the final contraction set (10 
sets), [Ca2+]i in DIA was elevated ~30% (P < 0.01) above precontraction baseline vs. ~10% for 
CONT. As shown in Figure 2.4, isometrically evoked active force in CONT decreased ~30% 
within a given set of contractions, which was less than the ~40% seen for DIA (1th; P < 0.01). 
At the start of set 5, relative force in CONT was ~90% of initial baseline compared with ~60% 
for DIA, indicating a greater compromise of tension recovery after contractions in DIA. 
Moreover, for the final (10th) set, the muscle force of the first and last 5 contractions in DIA 
was significantly lower compared with CONT. 
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Table 2.1. Body weight and blood glucose in control and diabetic rats 
 
 
 
 
 
 
 
 
 
 
 
CONT
DIA
Body Weight, g
10 wk age 14 wk age Blood Glucose, mg/dl
237.4 ± 3.7 311.7 ± 3.2 98.6 ± 6.1
232.4 ± 1.5 218.9 ± 4.2** 393.6 ± 35.3**
Values are expressed as means ± SE. CONT, control; DIA, diabetic. Total 43 rats were use the 
experiment of chapter 2, 3 and 4 in the thesis. (CONT, n = 21, DIA, n = 22). 
**Significant difference between CONT and DIA (P < 0.01).
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Figure 2.1: Absolute ratio (340 nm/ 380 nm fluorescence intensity) on before the start of the 
experiments in rat spinotrapezius muscles of control/healthy (CONT; white bar) and diabetes 
(DIA; black bar) rats. Values shown are means ± SE. 
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Figure 2.2: Typical example of changes in intracellular Ca2+ concentration ([Ca2+]i) by 
isometric contraction in rat spinotrapezius muscles of control/healthy (CONT; left) and 
diabetes (DIA; right) rats. Pre contraction (A and C) and 10th set (B and D). bar = 100 µm. 
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Figure 2.3: Effect of diabetes following isometric contractions in spinotrapezius muscles in 
vivo on intracellular Ca2+ concentration ([Ca2+]i). Fluorescence intensity ratio (R) was 
measured after 50th contraction of each set, and ratiometric quantified data were graphed as 
changes from precontraction (before 1st set) levels (R0). Values shown are means ± SE. 
(CONT: n = 9; DIA: n = 11). Greater [Ca2+]i in DIA compared with CONT (P < 0.05, main 
effect). A main effect for set number (P < 0.01) was found. Also, an interaction effect for 
treatment condition (CONT vs. DIA) and set number (P < 0.01) was found. Significantly 
different (*P < 0.05, **P < 0.01) from initial level for each condition. 
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Figure 2.4: Changes of relative active force during isometric contraction protocols. Force 
normalized to initial denotes the average of first and last five contractions of sets 1, 5, and 10 
from contraction protocol. Values shown are means ± SE. **Significance compared with initial 
value for CONT and DIA (P < 0.01). 
 
 
 
 
 
 
0
20
40
60
80
100
120
1~5 46~50 1~5 46~50 1~5 46~50
1 set 5 set 10 set
**
** **
**
**
**
**
**
**
CONT
DIA
R
e
la
ti
v
e
 f
o
rc
e
 (
%
o
f 
in
it
ia
l)
  
Chapter 2 : Intracellular Ca2+ dynamics following muscle contraction in diabetes 
 
35 
 
 
2.4 Discussion 
 
Muscle contraction is evoked by the transient elevation of [Ca2+]i, which under normal 
conditions, returns almost immediately to basal resting levels. In fact, previous studies 
indicated that [Ca2+]i accumulation may not occur following shorter bouts of isometric tetanic 
contractions (Balnave & Allen, 1995). On the other hand, longer lasting bouts of fatiguing 
muscle contractions do elicit muscle [Ca2+]i accumulation (Carroll et al., 1999; Gissel, 2000; 
Gissel & Clausen, 2003; Sonobe et al., 2008). It is possible that, initially, during isometric 
contractions, Ca2+ originates exclusively from the SR (i.e., intracellularly) with quantitatively 
little Ca2+ migrating across the sarcolemma. However, in healthy skeletal muscle, more 
chronic stimulation protocols, such as the 10 bouts used herein, cause a gradual [Ca2+]i 
accumulation that becomes evident after five sets of contractions and increased progressively 
thereafter. It is may be that the most likely source of the elevated [Ca2+]i was SR-released 
Ca2+, and its accumulation reflects a progressive inability for the SR to recover during each 
resting period. In the present investigation, elevation of [Ca2+]i postcontractions (i.e., at rest) 
in DIA was greater and occurred after fewer bouts of contractions compared with that in 
CONT. However, it is unlikely that these responses are directly responsible for the DIA 
tension deficits. Specifically, Allen et al. (Allen et al., 2008b) showed the beneficial effects of 
caffeine, which enhanced/restored force development in repetitive tetanic 
stimulation-fatigued isolated single muscle fibers via increased SR Ca2+ release. They 
proposed that it was the impairment of Ca2+ release from the SR, which constituted a key 
factor in the fatigue development (Allen & Westerblad, 1995). 
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Although the protein content per se did not change in DIA, we speculate that the most 
likely source of the elevated [Ca2+]i was SR-released Ca2+, and its accumulation reflects a 
progressive inability for the SR to recover during each resting period. Because Ca2+uptake by 
the SR is actively transported, it is associated with an ATP supply level. Kindig et al. (Kindig 
& Poole, 1998) found that peripheral circulatory function of STZ-diabetic rats is decreased. 
The reduction in metabolic potential induced by this ischemia and the associated 
hypoxic/anoxic environment may be responsible, in part, for the observed accumulation of 
[Ca2+]i in DIA. In fact, previous studies demonstrated that ischemia induced stress increased 
[Ca2+]i in skeletal muscle (Ivanics et al., 2000). 
The importance of prolonged elevation of resting [Ca2+]i after contractions likely relates to 
the muscle weakness and/or activation of proteolytic pathways in healthy muscle (Westerblad 
et al., 1993; Chin & Allen, 1996; Verburg et al., 2005). One plausible mechanistic link between 
the proteolysis of cytoskeletal proteins and elevated [Ca2+]i is activation of Ca2+-activated 
neutral proteases (calpains) (Goll et al., 2003; Verburg et al., 2005). The repeated eccentric 
contraction protocol induces muscle damage causing calpain-3 autolysis and elevated [Ca2+]i 
immediately after contractions (Sonobe et al., 2010). Therefore, the dysfunction of [Ca2+]i 
homeostasis in diabetes may be associated with the diabetogenic fragility, such as muscle 
atrophy or damage. 
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2.5 Summary 
 
This chapter demonstrates the effects of diabetes on [Ca2+]i accumulation following 
muscle contraction in in vivo spinotrapezius preparation models. This results, diabetes 
induced the elevation of [Ca2+]i following repeated tetanic contraction compared to healthy 
skeletal muscle. It is known that elevated [Ca2+]i activates calpains and may, therefore, be 
involved in the chronic morphological changes characteristic and the decline of the muscle 
contractile function in diabetes. 
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Chapter 3 
Intracellular Ca2+ uptake dynamics in diabetic skeletal 
muscle 
 
3.1 Introduction 
 
Maintenance of Ca2+ homeostasis is generally accepted that limitations of cellular 
organelle (e.g., SR and mitochondria). In skeletal muscle, the [Ca2+]i in normally, i.e., in the 
unstimulated state kept very low, ~0.1 µM (Armstrong et al., 1991). When cells are stimulated, 
Ca2+ is mobilized from its source(s) into the cytoplasm, and as a result, local or global [Ca2+]i 
become high enough to evoke cellular responses. Generally, in the Ca2+ uptake, it is also 
known that the SR Ca2+-ATPase performs the critical function of sequestering Ca2+ from the 
cytoplasm at the expense of ATP hydrolysis. Interestingly, previous studies reported that the 
[Ca2+]i dysregulation of diabetic muscle occurs in the presence of an enhanced SR function, at 
lease in vitro (Ganguly et al., 1986; Ganguly et al., 1987; Taira et al., 1988; Taira et al., 1991). 
However, there are no direct measurements of Ca2+ handling in diabetic in vivo models. 
In addition, skeletal muscle has a unique system such as Ca2+ release by the action of 
Ca2+ alone without the simultaneous action of other activating processes, called a 
“calcium-induced calcium release; CICR” (Endo, 2009). In CICR system in skeletal muscle,
  
Chapter 3 : Intracellular Ca2+ uptake dynamics in diabetes 
 
 
39 
 
ryanodine receptors (RyR) play a crucial role in the Ca2+ release from SR in the cytoplasmic. 
 Thus, the purpose of the present study was to test the hypothesized that, the rise in 
[Ca2+]i evident in skeletal muscles of diabetic rats following repeated bouts of muscle 
contractions (experiment result of Chapter 1) would be associated with attenuation of the 
Ca2+-handling system (i.e., decreased cytoplasmic Ca2+-buffering capacity) within the in vivo 
environment, using a microinjection method. 
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3.2 Methods 
3.2.1 Experimental protocol 
 
Muscle preparation and image analysis were performed, as described in the thesis (the 
Chapter 2). In the microinjection method, capillary micropipettes were generated with a tip of 
10 µm in diameter, which was achieved by custom grinding and inserted into the selected 
single muscle fiber using a micromanipulator precision-controlled advancer (MMO-220A; 
Narishige, Tokyo, Japan). Subsequently, using a microinjector (IM300; Narishige, Japan), a 
single muscle fiber was microinjected with 2 mM Ca2+ solution by microinjection at 35 psi 
(24,000 Pa) for 1 s. Criteria for successful injection included an unchanged [Ca2+]i in adjacent 
muscle fibers. Fluorescence images were captured by a high-sensitivity CCD digital camera 
(ORCA-Flash2.8; Hamamatsu Photonics, Hamamatsu, Japan) using image-capture software 
(NIS-Elements Advanced Research; Nikon, Tokyo, Japan) at a 1-s exposure for 60 s after 
injection. Pilot studies confirmed that insertion of the capillary micropipette itself did not 
induces any [Ca2+]i change (Figure 3.1). In addition, the microinjection of Ca2+-free solution 
(145 mM KCl, 3.5 mM NaCl, 1 mM MgCl2, 6.5 mM NaOH, and 10 m HEPES) was an 
unchanged [Ca2+]i (Figure 3.2).  
 
3.2.2 Statistical analysis 
 
Values are expressed as means ± SE. Statistical analyses were performed in Prism 
version 4.0 (GraphPad Software, San Diego, CA). Two-way repeated-measures ANOVA and 
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Bonferroni post hoc test were used for group differences in [Ca2+]i levels. The level of 
significance was set at P < 0.05. 
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Figure 3.1: Changes in intracellular Ca2+ concentration ([Ca2+]i) by insertion of the capillary 
micropipette in rat spinotrapezius muscle. Insertion of the capillary micropipette itself did 
not induce any [Ca2+]i change. Fluorescence was measured continuously during the 90 s, and 
ratiometric quantified data were graphed as changes from precondition (i.e., -30 s) levels (R0). 
Values shown are expressed as means ± SE (N = 1, n = 9). N = number of animals. n = number 
of muscle fibers. 
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Figure 3.2: Changes in intracellular Ca2+ concentration ([Ca2+]i) by microinjection of Ca2+-free 
solution in rat spinotrapezius muscle. Microinjection by Ca2+-free solution did not induce any 
[Ca2+]i change. Fluorescence was measured continuously during the 90 s, and ratiometric 
quantified data were graphed as changes from precondition (i.e., -30 s) levels (R0). Values 
shown are expressed as means ± SE (N = 1, n = 4). N = number of animals. n = number of 
muscle fibers. 
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3.3 Results 
 
Elevations of [Ca2+]i following Ca2+ microinjections were significantly higher in CONT 
compared with DIA (Figures 3.3 and 3.4). The high [Ca2+]i region (see Figure 3.3; region of 
interest; ROI) after the injection was larger and more pronounced in CONT than DIA (Figure 
3.4, B vs. F). The [Ca2+]i peak value of CONT occurred 6–8 s after the injection. In contrast, 
the [Ca2+]i peak value of DIA was far lower and was evidenced earlier than CONT (i.e., 4–6 s 
after the injection, Figure 3.4). In CONT muscles following the [Ca2+]i peak, [Ca2+]i fell rapidly 
for 10–15 s to stabilize at 8–10% above the initial baseline. On the other hand, [Ca2+]i in DIA 
muscle fibers rose ~8–10% above baseline and did not decrease subsequently (i.e., to the 60-s 
observation mark, Figure 3.4). 
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Figure 3.3: Typical example of changes in intracellular Ca2+ concentration ([Ca2+]i) by 
microinjection in rat spinotrapezius muscle. The injection site is shown with an arrow. The 
single muscle fiber targeted is demarcated by the dashed lines and the specific region of 
interest (ROI) is shown in the box. A–H: time points corresponding to thesis in Figure 3.4. 
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Figure 3.4: Effect of Ca2+ microinjection in individual spinotrapezius myocytes in vivo on 
intracellular Ca2+ concentration ([Ca2+]i). Fluorescence was measured continuously during the 
90 s, and ratiometric quantified data were graphed as changes from precondition (i.e., -30 s) 
levels (R0). Values shown are expressed as means ± SE (CONT: N = 6, n = 13, DIA: N = 5, n = 
7). N = number of animals. n = number of muscle fibers measured. There was a significant 
interaction effect for treatment condition (CONT vs. DIA) and time course of injection (P < 
0.05). *Significant difference (P < 0.05) between CONT and DIA for the same time points. 
Inset: bar graph shows rate of [Ca2+]i change at the peak and 60 s following injection. 
**Significant difference (P < 0.01) between peak and 60 s. A and E: precondition. B and F: just 
after injection. C and G: postcondition (15 s) and D and H: postcondition (60 s). CONT is A to 
D. DIA is E to H. 
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3.4 Discussion 
 
The failure of diabetes-related Ca2+ homeostasis may be associated with the compromised 
SR function. In previous studies using cardiac muscle, decreased SR Ca2+ transport and SR 
Ca2+ content have been detected in animal diabetic models (Choi et al., 2002; El-Omar et al., 
2004). However, there are conflicting reports on the capability of the SR to function in diabetic 
skeletal muscle. Dhalla and colleagues have reported that SR Ca2+ transport activity actually 
increases in skeletal muscle during the development of diabetes (Ganguly et al., 1986; Taira 
et al., 1991). On the other hand, and as noted above, Racz et al. (Racz et al., 2009) recently 
reported that level of SR Ca2+-ATPase protein declined in STZ diabetic rats. With respect to 
an in vivo experimental model (circulation intact), I believe that the present investigation is 
the first to use Ca2+ solution microinjection directly into the cytoplasm to determine the 
impact of DIA on the SR system. Figures 3.1 and 3.2 provide strong evidence that diabetes 
impairs Ca2+ handling in skeletal muscle. 
In cardiac muscle, CICR is considered to be the physiological mechanism responsible for 
cardiac muscle contraction (Fabiato & Fabiato, 1979; Stern, 1992; Sham et al., 1995). In 
skeletal muscle, however, the primary mechanism of physiological Ca2+ release is not CICR, 
but rather interaction between the voltage sensor of the t-tubule membrane, the 
dihydropyridine receptor and the RyR (Schneider, 1994; Endo, 2009). RyR1 is the primary 
isoform in mammalian skeletal muscle (Sorrentino, 1995). As all types of RyR (i.e., RyR1, 
RyR2, and RyR3) show CICR activity (Endo, 2009), the present investigation can quantify 
dynamically the Ca2+ release by the SR system. This study reveal that diabetic rats 
significantly decreased peak [Ca2+]i following Ca2+ injection. In cardiomyocytes, previous 
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studies indicated that there was a lower density of RyR and a quantitative relationship 
between the altered contraction-relaxation cycle and reduced Ca2+ release (Reuter et al., 2008; 
Stolen et al., 2009; Howarth et al., 2011). In fact, Venetucci et al. (Venetucci et al., 2007) 
reported a lower transient amplitude of [Ca2+]i consistent with a decreased SR calcium 
content. 
An important role of the SR system is Ca2+ reuptake to maintain [Ca2+]i at extremely low 
levels. In the our research, the DIA myocytes had almost no discernible [Ca2+]i recovery after 
Ca2+ injection. However, relationship between the attenuation of the Ca2+-handling system 
and SR Ca2+ regulatory protein expression in diabetic skeletal muscle is unknown. 
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3.5 Summary 
 
This chapter examined that Ca2+ release and uptake dynamics in vivo in individual 
spinotrapezius myocytes following Ca2+ injection. In the present study hypothesized that, a 
pronounced dysfunction of Ca2+ release and uptake dynamics was identified in diabetic 
skeletal muscle. The principal original findings include the following. The present study 
demonstrated that Ca2+ release and uptake (significantly decreased peak [Ca2+]i and the 
buffering of [Ca2+]i following Ca2+ injection) dynamics in vivo in diabetic skeletal muscle is 
impaired. It be suggests that diabetic condition cause to the impairment of CICR activity 
(Ca2+ release from SR). In addition, diabetic myocytes had almost no discernible [Ca2+]i 
recovery after Ca2+ injection and thus, it may be that the force production in diabetic skeletal 
muscle is impaired, while fatigability and muscle fragility are increased. 
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Chapter 4 
Evaluation of the factors associated with intracellular 
Ca2+ handling on diabetic skeletal muscle 
 
4.1 Introduction 
 
In diabetes mellitus, there is a failure to maintain healthy muscle termed diabetic 
myopathy (D'Souza et al., 2013). Not only is muscle mass decreased but the muscle fibers are 
more fragile and fatigable in diabetic animal models (Cotter et al., 1989; Sanchez et al., 2005; 
Aughsteen et al., 2006). Similarly, in humans diabetes is associated with chronic neuropathy 
which has been implicated in the decreased muscle mass and force production (Andersen et 
al., 1996; Andersen et al., 1997; Andersen et al., 2004; Andersen et al., 2005). 
In muscle contraction, it is generally accepted that Ca2+ handling (i.e., Ca2+-release and 
reuptake) by the SR is a crucial element in the control of excitation–contraction coupling 
(Figure 4.1). In the thesis, revealed a substantial degree of impairment in Ca2+ regulation 
following muscle contraction in vivo in diabetes (Chapter 2 and 3). However, relationship 
between an impairment of [Ca2+]i homeostasis and SR Ca2+-regulatory protein expression in 
diabetic skeletal muscle is unknown. Also, recent study suggested that mitochondria play a
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crucial role in the buffering of [Ca2+]i for maintaining physiological Ca2+ regulation (Pan et al., 
2013) (Figure 4.1). Thus, this study examined that SR Ca2+ regulatory proteins expression 
levels (Ca2+ uptake and release) and mitochondrial oxidative enzyme activity in diabetic 
skeletal muscle. 
 
 
 
 
 
 
Figure 4.1: Schematic diagram of intracellular mechanisms for Ca2+ regulation 
post-contraction(s) in skeletal muscle. Stimulation (e.g., membrane potential) induces a Ca2+ 
release and reuptake by sarcoplasmic reticulum (SR) and mitochondria. 
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4.2 Methods 
4.2.1 Histology 
 
    Experiment was performed, as described in the thesis (the Chapter 2). At the end of the 
experiments (Chapter 2 and 3), the spinotrapezius muscle was resected under anesthesia. 
The tissue blocks were frozen rapidly in isopentane cooled in liquid nitrogen. Serial sections of 
10 µm were made with a cryostat (CM1510; Leica, Wetzlar, Germany) at －20°C and mounted 
on polylysine-coated slides. Whole sections were stained for hematoxylin-and-eosin (HE), 
succinate dehydrogenase (SDH), and slow-type myosin heavy chain (MHC).  
    The SDH activities in individual muscle fibers in histological sections were examined as 
an index of mitochondrial volume density. Sections were incubated at 37°C for 45 min in a 
medium consisting of 0.2 M sodium phosphate buffer pH 7.5, containing 0.2 M sodium 
succinate and 1.2 mM nitroblue tetrazolium.  
    Mouse-monoclonal slow MHC antibody (diluted 1:40 in PBS) supplied by Novocastrate 
Laboratories (Leica Biosystems) was used to identify slow-twitch fibers. The sections were 
allowed to warm to room temperature and incubated in PBS (pH 7.5) at 25°C before further 
incubation with the primary antibody in a humidified box overnight at 4°C. Vectastain ABC 
kit (PK-6102; Vector Laboratories, Burlingame, CA) was used to reveal the 
immunohistochemical reaction, according to the manufacturer’s instructions. Then, DAB 
peroxidase substrate kit (SK-4100; Vector Laboratories) was used as a chromogenic reaction. 
In photographs of serial sections, slow MHC-stained muscle fibers were identified, and 
nonstained fibers were considered to be fast twitch. SDH activity was recorded using a 
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camera (E800, 0.30 numerical aperture; Nikon) at 10× magnification and analyzed 
subsequently in ImageJ (NIH, Bethesda, MD). The cross-sectional areas and SDH activities 
were measured by tracing fiber outlines of ~220 fibers from the muscle sections. The images 
were digitized as graylevel pictures. Each pixel was quantified as one of 256 gray levels and 
then automatically converted to optical density using ImageJ software. 
 
4.2.2 Western blot analysis 
 
Western blotting was performed to determine the protein expression levels of SR 
Ca2+-ATPase 1 (SERCA1), SR Ca2+-ATPase 2 (SERCA2), and ryanodine receptor (RyR) in 
spinotrapezius muscle from CONT and DIA rats. The spinotrapezius muscles were removed 
and homogenized in ice-cold lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 
mM EGTA, 200 mM NaF, 20 mM sodium pyrophosphate, 1 mM NaVO4 mM, 1% Nonidet P-40, 
10% glycerol) with Protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan) and PhosSTOP 
phosphatase inhibitor cocktail (Roche Applied Science, Indianapolis, IN). Homogenates were 
centrifuged at 14,000 rpm for 30 min at 4°C. Supernatant proteins were then quantified using 
BCA protein assay kit (Thermo Scientific, West Palm Beach, FL). The sample (10 µg total 
protein per lane) were separated on 7.5% (for SERCA1 and SERCA2) or 4% (for RyR) 
polyacrylamide gels for 50 min at 150 V and then transferred to Amersham Hybond-P 
membranes (GE Healthcare, Buckinghamshire, UK) for 60 or 100 min at 72 mA using the 
semidry method. After the transfer, the membranes were blocked with Blocking One or 1% 
skim milk (Nacalai Tesque) at room temperature for 1 h. After blocking, the membranes were 
then incubated with primary antibodies (anti-SERCA1 IIH11 antibody, 1:2,500; Thermo 
Scientific, MA3-911; anti-SERCA2 2A7-A1 antibody, 1:2,000; Thermo Scientific, MA3-919; 
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and anti-RyR, 34C antibody, 1:5,000, Thermo Scientific, MA3-925) at 4°C for overnight. Then, 
the membranes were added to goat anti-mouse IgG linked to peroxidase (SC-2055; Santa 
Cruz Biotechnology, Santa Cruz, CA) for 1 h at room temperature. The bound antibodies were 
detected by Chemi-Lumi One Super Kit (Nacalai Tesque) and analyzed with ImageQuant 
LAS-4000 (GE Healthcare Life Sciences, Tokyo, Japan). SERCA1, SERCA2, and RyR protein 
levels were expressed relative to α-tubulin antibody (1:1,000, GT114; GeneTex, Irvine, CA) 
and normalized to the CONT samples. 
 
4.2.3 Statistical Analysis 
 
All experimental data are expressed as means ± SE. All statistical analyses were 
performed in Prism version 4.0 (GraphPad Software, San Diego, CA). Two-way 
repeated-measures ANOVA and Bonferroni post hoc test were used for group differences in 
SDH activity. T-tests were used for histological data, and relative protein levels. The level of 
significance was set at P < 0.05. 
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4.3 Results 
 
Figure 4.2 shows transverse sections of the spinotrapezius muscles of CONT and DIA 
rats stained for HE, SDH activity and MHC slow. 
DIA rats evidenced a significant reduction in spinotrapezius fast-twitch fiber 
cross-sectional area (Table 4.1). Also, muscle fiber type shifts from fast to slow were found in 
DIA (32.5 ± 2.0% to 45.1 ± 5.9%, P < 0.01). Figure 4.3 shows histograms of SDH activity in 
each muscle fiber cross-sectional area distribution for CONT and DIA. DIA decreased SDH 
activity significantly below that found in CONT in all fiber cross-sectional area categories, 
except the largest (i.e., 2,500 µm2). 
Figure 4.4 shows the sarcoplasmic reticulum-related proteins (SERCA1, SERCA2, and 
RyR). No differences (P > 0.05) in SERCA1 and SERCA2 expression levels were noted 
between CONT and DIA (Figure 4.3, A and B), whereas RyR content was decreased ~50% (P < 
0.05) in spinotrapezius muscles of DIA compared with CONT (Figure 4.4, C). 
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Table 4.1. Histological features of spinotrapezius muscle in control and diabetic rats 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONT
DIA
Muscle Composition, %
Slow type
32.5 ± 2.0 1149.2 ± 42.4 2014.5 ± 134.5
45.1 ± 5.9** 985.3 ± 80.3 1360.4 ± 88.6**
Values are expressed as means ± SE. CONT, control; DIA, diabetic. 
n = 7/group for the histological parameters. 
**Significant difference between CONT and DIA (P < 0.01).
Cross-Sectional Area, µm2
Slow type Fast type
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Figure 4.2: Transverse sections of the spinotrapezius muscles of control (CONT; left) and 
diabetes (DIA; right) rats stained for hematoxylin-and-eosin (HE; A and D), succinate 
dehydrogenase (SDH) activity (B and E) and slow-type myosin heavy chain (MHC slow; C and 
F). Scale bar = 50 µm. 
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Figure 4.3: Histograms of SDH activity in each myofiber size distributions for control (CONT) 
and diabetes (DIA) rats. Values shown are means ± SE. *Significantly different (P < 0.05) 
between CONT and DIA.  
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Figure 4.4: Expression of SR Ca2+-ATPase (SERCA) 1, SERCA2 and ryanodine receptor (RyR) 
in spinotrapezius muscle from control (CONT) and diabetes (DIA) rats. Representative 
Western blot showing SERCA1 protein (A) and SERCA 2 protein (B). There were no 
significant differences between CONT and DIA. Western blot showing RyR protein (C). RyR 
expression in DIA was lower compared with CONT (*P < 0.05). Values shown are expressed as 
means ± SE (CONT: n = 8; DIA: n = 8). 
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4.4 Discussion 
 
The rat spinotrapezius muscle possesses the following important characteristics that 
make it an excellent candidate for intravital microscopy studies: 1) it can be exteriorized and 
transilluminated without disruption of the nervous or primary vascular supplies (Poole et al., 
1997; Kindig et al., 1998; Bailey et al., 2000; Kindig et al., 2002); 2) it comprises both principal 
fiber types (41% Type I; and 59% Type II); and 3) its oxidative capacity approximates that 
found in the untrained human quadriceps (Delp & Duan, 1996; Leek et al., 2001). Until the 
present investigation, the impact of the DIA condition on the muscle fiber composition and 
oxidative enzyme activity was unknown. We found that, in addition to DIA causing a 
pronounced atrophy in the fast-twitch fibers, there was a shift toward a greater slow-twitch 
fiber composition (Figure 4.1 and Table 4.1). This result was consonant with previous studies 
showing that the STZ-induced diabetic rat endures a fast-twitch, fiber-specific atrophy of 
hindlimb muscles (Cotter et al., 1989; McGuire & MacDermott, 1999; Aughsteen et al., 2006). 
Also, DIA induced a profound decrease of SDH activity compared with CONT (Figure 4.2), as 
predicted from hindlimb locomotory muscle studies (Klueber & Feczko, 1994; Gordon et al., 
2010). 
Chapter 3 in this thesis reveals that diabetic rats significantly decreased peak [Ca2+]i 
following Ca2+ injection. Correspondingly, attenuation of the Ca2+ release response in DIA was 
accompanied by reduction of RyR protein level in the spinotrapezius muscle (Figure 4.3). 
Thus, strongly support the hypothesis that diabetes cause to the impairment of CICR activity. 
An important role of the SR system is Ca2+ reuptake to maintain [Ca2+]i at extremely low 
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levels. In the Chapter 3 in this thesis, the DIA myocytes had almost no discernible [Ca2+]i 
recovery after Ca2+ injection. On the other hand, no significant difference was found in the 
protein expression level of the SR Ca2+ pump (SERCA1 and SERCA2) between CONT and 
DIA (Figure 4.3). Taira et al. (Taira et al., 1991) reported that Ca2+ transport activities are 
enhanced in the skeletal muscle of STZ rats using in vitro biochemical assay. They suggested 
that enhanced Ca2+ transport activities may be related to the many metabolic changes arising 
from the insulin deficiency in the STZ model. For example, the high level of circulating 
catecholamines induced by diabetes may be associated with an increased Ca2+ pump function 
(Ganguly et al., 1987). Recently, Funai et al. (Funai et al., 2013) showed impairment in SR 
Ca2+ transport activity without changes in SERCA1 expression in fatty acid synthase 
knockout mice. Thus, in the present investigation, altered fatty acid synthetase in DIA may 
have altered SERCA1 activity independent of protein levels and, as a result, impacted Ca2+ 
dynamics in DIA following the Ca2+ injection. 
Another putative source of Ca2+ uptake is the mitochondria, and it is known that Ca2+ 
release from the SR through RyR also promotes Ca2+ uptake into neighboring mitochondria 
(Csordas et al., 2006; Yi et al., 2012). In skeletal muscle fibers, the mitochondrial reticulum is 
located adjacent to the SR and close to Ca2+ release units (Boncompagni et al., 2009), 
indicating that mitochondria and SR function in a complementary fashion to regulate [Ca2+]i 
dynamics. This notion is supported by the observation that mitochondrial poisoning by 
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone decreases the amplitude of the Ca2+ 
transient associated with excitation-contraction coupling in isolated skeletal muscle fibers 
(Caputo & Bolanos, 2008). Moreover, Eisner et al. (Eisner et al., 2010) found that temporal 
loss of connectivity of the mitochondria in skeletal myotubes compromised mitochondrial Ca2+ 
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buffer capacity. The lowered SDH activity in DIA indicates a reduced quantity and/or quality 
of mitochondria that may, consequently, contribute to the impaired [Ca2+]i regulation 
demonstrated herein (Chapter 2 and 3). 
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4.5 Summary 
 
This chapter examined that morphological properties and SR Ca2+ regulatory proteins 
(Ca2+ release; RyR, Ca2+ uptake; SERCA1 and SERCA2) expression and mitochondrial 
oxidative enzyme activity in spinotrapezius muscles in diabetic rats. The principal original 
findings include the following. 1) In spinotrapezius muscles, diabetes induced a profound 
fast-twitch, fiber-specific atrophy and decrease of SDH activity. 2) The present study 
demonstrated that RyR protein content in spinotrapezius muscle of diabetic rats is decreased, 
whereas no differences in SERCA1 and SERCA2 expression levels in spinotrapezius muscles 
from diabetic rats compared with healthy rats. Diabetes condition is involved in the chronic 
morphological changes (myocyte atrophy, loss of mitochondrial capacity). In addition, 
attenuation of the [Ca2+]i homeostasis in diabetic skeletal muscle may be contribute to 
decreased in Ca2+ uptake of mitochondrial itself.  
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Chapter 5 
Effect of muscle fiber type on intracellular Ca2+ 
dynamics of diabetes. 
 
5.1 Introduction 
 
Type I diabetes impairs Ca2+ handling in many tissues such as cardiac muscle, platelets, 
kidney and liver (Levy et al., 1994; Guerrero-Hernandez & Verkhratsky, 2014). In skeletal 
muscle, the diabetic state increases resting [Ca2+]i and induces activity of Ca2+-dependent 
proteolytic pathways (Nakagawa et al., 1989; Zemel et al., 1990; Baviera et al., 2007; Baviera 
et al., 2008).  
The rate of skeletal muscle contraction-relaxation cycling depends on the capacity for 
Ca2+-release-reuptake of the SR. In particular, sequestration of Ca2+ from the cytoplasm into 
the SR via the SERCA permits muscle relaxation (Dux, 1993; MacLennan et al., 1997; Barclay 
et al., 2007). There is no indication of impaired SR Ca2+ sequestration capacity in either 
animal fast-twitch (increased calmodulin, sarcolemmal Ca2+ channels numbers and SR Ca2+ 
transport activity (Morley et al., 1982; Lee & Dhalla, 1992) or slow twitch muscle in 
STZ-diabetic rats (Ganguly et al., 1986; Ganguly et al., 1987; Taira et al., 1988; Taira et al., 
1991). In the absence of impaired SR-Ca2+ handling in diabetes it is likely that the 
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mechanistic bases for diabetes-induced [Ca2+]i dysregulation resides elsewhere. Diabetes 
induces a fiber-type specific effect predominantly targeting fast twitch fibers/muscles (Wang 
& Pessin, 2013). These fibers/muscles are characterized by a very different oxygenation state 
(PmvO2) than their slow twitch counterparts both during and following contractions 
(McDonough et al., 2001; Behnke et al., 2003) and it is therefore possible that the impaired 
SR-Ca2+ handling in these fibers in diabetes is related to their PmvO2 profile.   
Recently, Kano and colleagues succeeded in measuring in vivo [Ca2+]i within the mixed 
fiber-type rat spinotrapezius muscle (Delp & Duan, 1996) following contractions (Sonobe et al., 
2008; Sonobe et al., 2010). In this preparation intramyocyte injection of a high [Ca2+]i bolus 
revealed a depressed Ca2+ buffering capability in diabetes which corresponded with the 
elevated post-contraction [Ca2+]i (Chapter 3). Unfortunately, that preparation did not permit 
resolution of between fiber type effects on the profile of [Ca2+]i following contraction in Type I 
diabetes which remain to be resolved. 
The greater physiological fragility of fast twitch fibers under atrophic conditions such as 
diabetes may relate, in part, to impaired microvascular structure (Sexton et al., 1994) and 
hemodynamics (Kindig et al., 1998). These effects impact the fine balance of O2 delivery-to-O2 
utilization, at least within the spinotrapezius muscle, such that very low PmvO2’s are evident 
at rest and both during and following contractions (Behnke et al., 2002; Padilla et al., 2006, 
2007). It is conceivable that the ~60% fast twitch fibers that comprise the spinotrapezius 
(Delp & Duan, 1996) are driving these aberrant PmvO2 profiles. 
Predicated on the evidence presented above that SERCA activity is preserved/ increased 
in isolated intact (or skinned) single muscle fibers in diabetes we rationalized that impaired 
[Ca2+]i homeostasis may relate to impaired microcirculatory hemodynamics (i.e., oxygenation, 
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PmVO2 ) during/following contractions. To address this question it is crucial to maintain 
essential tenets of physiological function including blood flow, O2 supply, and ATP utilization 
and assess the predations of diabetes in muscles comprised of disparate fiber types (i.e., slow 
twitch soleus versus fast twitch extensor digitorum longus). Specifically, we tested the 
hypotheses that following fatiguing tetanic contractions in diabetes: 1. Any rise in resting 
[Ca2+]i evident in slow-twitch (Type I) would be exacerbated in fast-twitch (Type II) muscle. 2. 
These elevated [Ca2+]i levels would relate to derangement of PmvO2 rather than sarcoplasmic 
reticulum (SR) dysfunction per se.  
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5.2 Methods 
5.2.1 Muscle preparation 
 
Animals of information using experiment were performed, as described in the thesis 
(Chapter 2). All experimental techniques, the extensor digitorum longus (EDL) and soleus 
(SOL) muscles were used in this study. The EDL is composed of primarily fast-twitch fibers, 
whereas the SOL is composed of primarily slow-twitch fibers (Delp & Duan, 1996). Each 
muscle were resected the distal tendon and gently exteriorized with minimal blood loss and 
tissue/microcirculatory damage. The exposed muscle tissue was kept moist by superfusing 
with warmed Krebs-Henseleit buffer (KHB; 132 mM NaCl, 4.7 mM KCl, 21.8 mM NaHCO3, 2 
mM MgSO4, and 2 mM CaCl2) equilibrated with 95% N2-5% CO2 and adjusted to pH 7.4, at 
37°C. 
 
5.2.2 Intracellular Ca2+ measurement 
 
Intracellular Ca2+ measurement were performed, as described previously (Chapter 2 and 
3). The fluorescent Ca2+ indicator Fura-2 AM (5 mM; Dojindo Laboratories, Kumamoto, 
Japan) was dissolved in DMSO and Pluronic F-127 and dispersed into KHB solution at a final 
concentration of 40 µM. The muscles were incubated in Fura-2 AM/KHB solution for 60 min 
on a 37°C hotplate. After incubation, muscles were rinsed with dye-free KHB solution to 
remove nonloaded Fura-2. 
The muscles loaded with Fura-2 AM were mounted on the 37°C glass hotplate (Kitazato 
Supply, Shizuoka, Japan) and observed by fluorescence microscopy using a ×4 objective lens 
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(0.20 numerical aperture; Nikon, Tokyo, Japan). Thereafter, 340-nm and 380-nm wavelength 
excitation light was delivered using a Xenon lamp equipped with appropriate fluorescent 
filters, and pairs of fluorescence images were captured through the 510-nm emission 
wavelength filter for ratiometry. Fluorescence images were captured by a high-sensitivity 
charge-coupled device digital camera (ORCA-Flash2.8; Hamamatsu Photonics, Hamamatsu, 
Japan) using image-capture software (NIS-Elements Advanced Research; Nikon, Tokyo, 
Japan). The fluorescence intensity of serial ratio images was normalized to the starting point 
(i.e., precondition, R0) of each experiment (R/R0). Pilot studies confirmed that the 340/380-nm 
ratio value (i.e., resting [Ca2+]i) was unchanged over the 90-min observation period, whereas 
in vitro state by surgically isolating was progressively-increasing in EDL and SOL muscles, 
respectively (n = 5-7). 
 
5.2.3 Microvascular PO2 measurement 
 
Before the muscle preparation, the carotid artery was isolated and, with the use of an 
introducer, cannulated with 22-G needle to provide a route of access for infusion of the 
phosphorescent probe [palladium mesotetra (4-carboxyphenyl) porphine dendrimer (R2); 15 
mg/kg], blood pressure measurement. The phosphor R2 was infused -15 min before the 
experimental procedure, and all experiments were conducted in a darkened room to prevent 
contamination from ambient light. PmvO2 was determined at 1-s intervals at rest, during 
contractions, and for a few minutes of subsequent recovery. 
The theoretical basis for phosphorescence quenching has been detailed previously 
(Rumsey et al., 1988). Briefly, the Stern-Volmer relationship (Rumsey et al., 1988) describes 
quantitatively the O2 dependence of the phosphorescent probe. R2 is a nontoxic dendrimer 
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(Lahiri et al., 1993) that binds completely to albumin at 38°C and pH 7.4, with a quenching 
constant of 409 mmHg1·s1 and lifetime decay in the absence of O2 of 601 µs (Pawlowski & 
Wilson, 1992; Lo et al., 1997). In addition to binding with albumin, the net negative charge of 
R2 also facilitates restriction of the compound to the vascular space (Poole et al., 2004). To 
determine PmvO2, a PMOD 2000 frequency domain phosphorometer (Oxygen Enterprises, 
Philadelphia, PA) was utilized. The common end of the bifurcated light guide was placed 2–3 
mm above the medial portion of either muscle. The excitation light was focused on an ～
2-mm-diameter circle of exposed muscle surface and samples blood within the 
microvasculature up to 500 µm deep. 
In the modeling of PmvO2 profiles, curve fitting was accomplished using KaleidaGraph 
software (Version 4.1, Synergy software, Reading, PA) and was performed on the PmvO2 data 
using a one-component model: 
PmvO2 (t) = PmvO2 (b) + ∆ PmvO2 [1 – e - ( t – TD ) / τ ] 
where PmvO2 (t) is a given time point, PmvO2 (b) is baseline (i.e., pre-contraction), and 
ΔPmvO2 is the decrease in PmvO2 from baseline to the end-stimulation values. 
To determine whether the one-component would best describe the PmvO2 response for 
either muscle, the goodness-of-fit for the model was determined via three criteria: (1) the 
coefficient of determination (i.e., r2), (2) the sum of the squared residuals term (i.e., χ2) and (3) 
visual inspection of the model fit to the data. Mean PmvO2 were determined by integration 
for 300 s from the end of tetanic contractions (i.e., off-transient). 
 
5.2.4 Stimulation 
 
For the contraction protocols, electrodes were placed on the distal tendon and proximal 
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side of EDL and SOL muscles. Following a 10–15 min post-surgery stabilization period, 
tetanus muscle contractions (100 Hz frequency, 4-8 V, no interval) by electrical stimulation 
were elicited in either the EDL or SOL muscle (in random order) for 2 min using a model 
stimulator. After the 2 min stimulation period, there was a stimulation-free recovery period 
for 10-20 min of each muscle. In force measurement, the wire attached to the distal tendon of 
EDL and SOL muscles was connected by fine wire to a strain gauge. Torque was monitored by 
computer using Mac Lab/8s (AD Instruments, Colorado Springs, CO) via a strain 
gauge-linked motor device (0–10 mN/m, full-scale deflection, model no. RU-72; NEC Medical 
Systems, Tokyo, Japan) during all contraction protocols. The muscle force during electrical 
stimulation was resolved as active force and during contraction (2-minute) plotted graphically 
as an index of fatigue. 
 
5.2.5 Histology 
 
At the end of the experiments, EDL and SOL muscle was resected under anesthesia.  
The tissue blocks were frozen rapidly in isopentane cooled in liquid nitrogen. Serial sections of 
10 µm were made with a cryostat (CM1510, Leica, Germany) at -20°C and mounted on 
polylysine-coated slides. Whole sections were stained for hematoxylin eosin (HE), succinate 
dehydrogenase (SDH), slow and fast myosin heavy chain (MHC). The SDH activities in 
individual muscle fibers in histological sections were examined and analyzed as described 
previously (Chapter 4). Mouse-monoclonal slow MHC antibody (diluted 1 : 40 in PBS) 
supplied by Novocastrate Laboratories (Leica Biosystems) was utilized to identify slow-twitch 
fibers. Mouse-monoclonal Fast MHC antibody isoforms were used monoclonal antibodies 
which specifically reacts with type IIA (SC-71, 1:1000), IIB (BF-F3, 1:100) supplied by 
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Developmental Studies Hybridoma Bank (University of Iowa, USA). The sections were 
allowed to warm to room temperature and incubated in phosphate buffered solution (PBS; pH 
7.5) at 25°C before further incubation with the primary antibody in a humidified box 
overnight at 4°C. Vectastain ABC kit (Vector Laboratories, Funakoshi, Japan) was used to 
reveal the immunohistochemical reaction according to the manufacturer’s instructions. The 
cross-sectional areas and SDH activities were measured by tracing fiber outlines of ~ 220 
fibers from the muscle sections. The images were digitized as gray level pictures. Each pixel 
was quantified as one of 256 gray levels and then automatically converted to optical density 
using ImageJ software. 
 
5.2.6 Western blot analysis 
 
For SR Ca2+-ATPase 1 (SERCA1), SR Ca2+-ATPase 2 (SERCA2) and ryanodine receptor 
(RyR) protein analysis, dissected EDL and SOL muscles were homogenized and analyzed as 
described previously (Chapter 4). 
 
5.2.7 Statistical analysis 
 
Values are expressed as means ± SE. Statistical analyses were performed in Prism 
version 4.0 (GraphPad Software, San Diego, CA). Two-way repeated-measures ANOVA and 
Bonferroni post hoc test were used for group differences in [Ca2+]i levels, muscle force, and 
histological data. T-tests were used for physical characteristic, relative protein levels, and 
model parameter for PmvO2. The level of significance was set at P < 0.05. 
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5.3 Results 
 
DIA rats evidenced significantly lower body mass and reduced muscle weight/body 
weight ratio for the EDL but not the SOL (Table 5.1). Fiber type composition was unchanged 
in DIA SOL whereas in DIA EDL there was an increased percentage of IIx fibers at the 
expense of IIb and all Type II fibers (a/x/b) were substantially atrophied (Figure 5.1, 5.2 and 
5.3). 
There was a modest reduction in oxidative capacity (SDH activity) in DIA SOL Type I 
and IIa fibers (Figure 5.3; F). Both SERCA1 and SERCA 2 protein levels increased in EDL but 
remained either unchanged or decreased in SOL (Figure 5.4). Ryanodine receptor protein was 
decreased 40% in EDL and unchanged in SOL. 
During the 120 s tetanic contraction all muscles exhibited a pronounced fatigue as 
evident from the precipitous decrease in force to ~10% initial in SOL and ~5% in EDL (Figure 
5.5). Whereas the force/fatigue profile in SOL was unchanged by the DIA condition the DIA 
EDL fatigued far faster than its healthy counterpart.  
The photomicrographs (Figure 5.6) and temporal profiles (Figure 5.7) capture the 
dynamics of in vivo [Ca2+]i at resting baseline and following the 120-s tetanic muscle 
contraction. In CONT EDL and SOL muscles [Ca2+]i decreased to baseline levels in 180-210 s 
and remained there throughout the rest of the 10-min recovery period. This was also the case 
for DIA SOL. However, in marked contrast, [Ca2+]i in DIA EDL did not decrease but rather 
increased during so-called recovery to a peak of 1.23 ± 0.03 at 600 s as seen clearly in the 
bottom panel (second from left) in Figure 5.7.  
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Surprisingly DIA increased baseline PmvO2 prior to contractions (Table 5.2 and Figure 
5.8). During the tetanic contraction the rate and extent (Δ) of PmvO2 decrease was accelerated 
by DIA in both SOL and EDL whereas following contractions the rate of PmvO2 recovery 
slowed drastically. The consequences of this slowed recovery differed substantially for the 
EDL versus SOL. Specifically, over the first 300 s post-contraction this phenomenon reduced 
the mean PmvO2 from ~28 mmHg to 21 mmHg (P < 0.05) whilst that for the SOL was 
unaffected by DIA (P > 0.05) (Figure 5.9). 
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Table 5.1. Body weight, blood glucose and muscle/body weight ratio in control and diabetic 
rats 
 
 
 
 
 
 
 
 
 
 
 
 
Body Weight, g
10 wk age 14 wk age
Blood Glucose, mg/dl Muscle / body weight ratio, mg/g
EDL SOL
234.3 ± 2.8 309.3 ± 2.7 99.0 ± 7.1 0.47 ± 0.01 0.42 ± 0.01
232.4 ± 1.5 218.9 ± 4.2** 370.6 ± 20.2** 0.39 ± 0.02** 0.42 ± 0.02
Values are expressed as means ± SE. CONT, control; DIA, diabetic. 
**Significant difference between CONT and DIA (P < 0.01).
CONT
DIA
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Figure 5.1: Transverse sections of extensor digitorum longus (EDL) muscle of control (CONT; 
left) and diabetes (DIA; right) rats stained for hematoxylin-and-eosin (HE), succinate 
dehydrogenase (SDH) activity, slow-type myosin heavy chain (MHC slow), type IIa myosin 
heavy chain (MHC IIa) and type IIb myosin heavy chain (MHC IIb). Scale bar = 50 µm. 
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Figure 5.2: Transverse sections of soleus (SOL) muscle of control (CONT; left) and diabetes 
(DIA; right) rats stained for hematoxylin-and-eosin (HE), succinate dehydrogenase (SDH) 
activity, slow-type myosin heavy chain (MHC slow) and type IIa myosin heavy chain (MHC 
IIa). Scale bar = 50 µm. 
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Figure 5.3: Muscle composition (A and B), cross sectional area (C and D) and succinate 
dehydrogenase (SDH) activity (E and F) of extensor digitorum longus (left; A, C and E) and 
soleus (right; B, D and F) muscles in control (CONT) and diabetes (DIA) rat. Values shown are 
means ± SE (n = 6 - 7). Significant difference between CONT and DIA (* P < 0.05, ** P < 0.01). 
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Figure 5.4: Expression of SR Ca2+-ATPase (SERCA) 1, SERCA2 and RyR in extensor 
digitorum longus (EDL) and soleus (SOL) muscles from in control (CONT; white bar) and 
diabetes (DIA; black bar) rat. Representative Western blot showing SERCA 1 protein (A), 
SERCA2 protein (B) and Ryanodine receptor (RyR) protein (C). Significant difference between 
CONT and DIA (* P < 0.05, ** P < 0.01). Values shown are means ± SE (n = 5 - 8). 
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Figure 5.5: Relative force profile during 120-sec muscle contractions in extensor digitorum 
longus (EDL; A) and soleus (SOL; B) muscles from in control (CONT; white bar) and diabetes 
(DIA; black bar) rat. Values are means ± SE. A significant difference between treatment 
conditions (CONT vs. DIA, P < 0.05) was found in EDL muscles. 
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Figure 5.6: Typical example of changes in intracellular Ca2+ concentration ([Ca2+]i) following 
120-sec contraction in rat extensor digitorum muscle (EDL) and soleus (SOL) muscle. 
Fluorescence images were continuously-captured with no delay following contraction. bar = 200 
μm 
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Figure 5.7: Effect of diabetes following 120-sec muscle contraction in extensor digitorum 
longus (EDL; A) and soleus (SOL; B) muscles in vivo on intracellular Ca2+ concentration 
([Ca2+]i). Fluorescence was measured continuously during the 120 to 600 s, and ratiometric 
quantified data were graphed as changes from precondition (i.e., -120 s) levels (R0). Values 
shown are expressed as means ± SE (n = 6-8). #Significant difference (P < 0.05) between 
control (CONT) and diabetes (DIA). *Significantly different (P < 0.05) from initial level for 
each condition. Dash lines were estimate value. 
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Figure 5.8: Typical example of dynamic microvascular partial pressure of oxygen (PmvO2) 
profiles for extensor digitorum longus (EDL; A) and soleus (SOL; B) muscles from control 
(CONT; ○) and diabetes (DIA; ●) rats. Time 0 represents the start of -120 sec of muscle 
contraction (On-transient phase), and defined the PmvO2 dynamics during recovery from 
contraction (0 ~ 600 sec) as off-transient phase.  
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Table 5.2. Microvascular PO2 kinetics during the on-and off-transient from contraction 
 
 
 
 
 
 
On-transient
25.5 ± 1.3 34.7 ± 2.8*
Values are means ± SE. CONT, control; DIA, diabetes. n = 6 ～ 7.
Significant difference between CONT and DIA (* P < 0.05, ** P < 0.01).
CONT DIA
EDL
CONT DIA
SOL
Baseline PmvO2, i.e., resting,
Torr
24.2 ± 1.5 32.4 ± 2.1**
Δ On-transient, Torr
TD, s
τ, s
Off-transient
PmvO2 after contractions, Torr
-17.9 ± 1.1 -31.7 ± 2.8** -10.2 ± 1.8 -17.9 ± 3.2*
11.8 ± 1.0 10.1 ± 1.2 17.0 ± 3.5 12.2 ± 2.5
7.6 ± 3.8 6.6 ± 2.7 28.3 ± 7.9 25.6 ± 6.8
Δ Off-transient, Torr
TD, s
τ, s
13.1 ± 2.4 12.6 ± 1.7 15.8 ± 2.1 17.9 ± 1.6
19.2 ± 5.4 20.9 ± 3.8 11.1 ± 1.9 14.0 ± 3.0
26.8 ± 3.3 40.7 ± 19.5 12.6 ± 4.6 23.5 ± 6.0
21.9 ± 4.9 92.2 ± 6.2** 28.0 ± 3.1 93.5 ± 20.1*
MRT, s 19.4 ± 4.5 16.7 ± 2.2 45.3 ± 7.9 37.8 ± 4.5
MRT, s 48.7 ± 4.1 133.0 ± 19.0** 40.7 ± 7.5 117.0 ± 18.2**
Mean microvascular PO2, Torr 27.9 ± 2.0 18.4 ± 1.9* 24.1 ± 2.4 25.9 ± 2.3
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Figure 5.9: Relationship between mean microvascular partial pressure of oxygen (PmvO2) 
during the first 300 s of recovery and intracellular Ca2+ concentration ([Ca2+]i) expressed as 
the R/R0 ratio. PmvO2 during the first 300 s of recovery kinetics for extensor digitorum muscle 
(EDL; A) and soleus muscle (SOL; B) in control (CONT) and diabetes (DIA) rat. *P<0.05 
versus CONT-EDL. 
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5.4 Discussion 
 
In Type I diabetes muscle structural and functional aberrations conflate to impair 
contractile performance and there is substantial evidence that [Ca2+]i dysregulation features 
center stage in this process.  For the first time this investigation has linked fiber-type 
specific dysregulation of in vivo [Ca2+]i homeostasis in diabetes with compromised muscle 
oxygenation following muscle contractions.  Specifically, the principal original findings 
include: 1) Diabetic fast-twitch (EDL, Type II) but not slow-twitch (SOL,Type I) skeletal 
muscles are more fatigable and, after a prolonged fatiguing tetanic contraction, EDL [Ca2+]i 
homeostasis cannot be recovered within a prolonged period.  2) SERCA1 and 2 protein 
expression is not depressed but rather is elevated in the EDL in diabetes. 3) Recovery of the 
post-exercise PmvO2 (mean PmvO2) is markedly depressed in the diabetic EDL (but not SOL).  
These findings support the concept that the mechanistic bases for the dysfunctional [Ca2+]i 
homeostasis and contractile performance in diabetic muscle may be the consequence of 
reduced oxygenation rather than down regulation of the SR Ca2+ uptake proteins. 
As found herein (Figures 5.3 and 5.4) the compelling weight of evidence from 
investigations in animals (and humans) supports that SERCA 1 and 2 protein expressions can 
be controlled independently of contractile proteins and thus increase in atrophic fast-twitch 
muscles in Type I diabetes.  For example, in diabetic animals SR Ca2+ uptake is elevated in 
the fast-twitch hamstring muscles (Ganguly et al., 1986; Ganguly et al., 1987; Taira et al., 
1988; Taira et al., 1991) and both Ca2+-ATPase activity and Ca2+ uptake are higher in vastus 
lateralis muscle from Type I diabetic patients versus matched non-diabetic controls (Harmer 
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et al., 2014).  
There is also substantial support for Type I diabetes either lowering or not changing 
SERCA protein expression in slow-twitch muscles (as seen in Figure 5.4).  Also in the SOL of 
streptozotocin diabetic rats Racz et al., reported that SR Ca2+-ATPase protein levels declined 
in the absence of myosin heavy chain alterations (Racz et al., 2009). In addition, SOL SERCA 
protein contents decrease during regeneration from notexin-induced muscle necrosis (Zador et 
al., 1998). From the above it is apparent that fast-twitch muscles are more vulnerable to 
atrophy and a plenitude of dysfunctions compared with their slow-twitch counterparts 
(present data and Wang & Pessin, 2013). It is fascinating that Type I diabetes can evoke 
dramatic anabolic changes with respect to the calcium protein function whilst simultaneously 
evoking catabolism of the contractile proteins. Resolution of the signaling mechanisms 
involved and the roles of Ca2+ and oxygen dysregulation in those signaling processes will 
constitute and important goal in combatting diabetes-induced skeletal muscle dysfunction. 
As exemplified by animal models the peripheral circulation is profoundly dysfunctional in 
diabetes (Kindig & Poole, 1998; Behnke et al., 2002; Padilla et al., 2006, 2007) raising the 
distinct possibility that acute and chronic diabetes-induced muscular deficits are driven, at 
least partially, by impaired oxygen transport. An abundance of evidence demonstrates that 
contractile function is exquisitely sensitive to increased or decreased blood oxygen content 
and muscle oxygen supply (Amann et al., 2006). Intramuscular hypoxia exacerbates 
intracellular perturbations (e.g., greater decrease in intracellular phosphocreatine, increase 
in free ADP, enhanced glycogenolysis) needed to support the energetic demand of the muscle 
(Wilson et al., 1979; Behnke et al., 2002).  
Our investigations have established that diabetes impairs PmvO2 kinetics during muscle 
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contractions in the rat spinotrapezius muscle (Padilla et al., 2007). This is an important 
observation with respect to the present findings, in part, because disease-associated changes 
in the on-kinetics often presage derangements in the off-kinetics. For instance, in the 
spinotrapezius (mixed fiber type) of rats in congestive heart failure, a condition that impacts 
PmvO2 on-kinetics (Diederich et al., 2002), the off-kinetics were slowed in proportion to the 
degree of left ventricular dysfunction (Copp et al., 2010).  
The present study focused on the PmvO2 kinetics following 120 s of a fused tetanic 
contraction.  The kinetics of PmvO2 during/following contractions provides information 
regarding the efficacy of the matching between muscle O2 supply and O2 demand and may be, 
to a certain extent, contraction protocol dependent (Kano et al., 2011; Kano et al., 2014). In 
the present investigation we used non-intermittent tetanic contractions model to highlight 
recovery dynamics after the muscle fatigue. Hence, it is expected that the PmvO2 kinetics 
after muscle contraction (off-transient) would be an insightful index of the oxygen supply 
itself as related to the oxygen utilization. The PmvO2 time constant (τ) was markedly 
increased for both EDL and SOL but this significantly depressed the mean PmvO2 only in the 
EDL where the [Ca2+]i homeostasis was deranged (Table 5.2 and Figures 5.9). 
In diabetes fast-twitch/glycolytic myosin-heavy chain (MHC) type II fibers (e.g., EDL) 
have decreased fiber cross-sectional area and impaired force production whereas 
slow-twitch/oxidative/MHC type I fibers (SOL) are affected to a lesser extent or not at all 
(Cotter et al., 1989; Cameron et al., 1990; Cotter et al., 1993; Stephenson et al., 1994; 
Lesniewski et al., 2003). The rise in resting [Ca2+]i following muscle contractions found in the 
present investigation has also been observed in isolated toad and mouse single muscle fibers 
from healthy animals (Chin & Allen, 1996; Rosser et al., 2009) and is a typical feature of 
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severely fatigued muscle.  It was especially interesting that it occurred in the present 
investigation only in the fast-twitch EDL of diabetic animals and it did so in the face of 
increased of SERCA protein expression (Figure 5.4). The present findings support the 
possibility that the diabetes-induced peripheral circulatory dysfunction (Kindig et al., 1998), 
and consequent reduction of recovery PmvO2 in EDL (Figure 5.9), rendered the enhanced SR 
proteins ineffective. 
Another putative source of Ca2+ uptake that must be considered is the mitochondria. 
Mitochondrial [Ca2+] is increased within a few milliseconds of the cytosolic [Ca2+] rise for both 
twitch and sustained tetanic contraction in vivo (Rudolf et al., 2004; Pozzan & Rudolf, 2009). 
This process can be compromised by loss of mitochondrial connectivity; at least in skeletal 
myotubes (Eisner et al., 2010). Further evidence supporting a crucial role for mitochondrial 
Ca2+ buffering emerges from mitochondrial Ca2+ uniporter expression knockout mice (Pan et 
al., 2013). Muscles from these animals have impaired isometric contraction force in the 
absence of detectable changes in skeletal muscle composition. It is clear that both 
mitochondrial Ca2+ permeability and  Ca2+ handling is deranged in fast-twitch muscles in 
diabetic rats (Lumini-Oliveira et al., 2010). In the present investigation the primary evidence 
for mitochondrial changes with diabetes was found in the soleus where a substantial decrease 
of SDH activity occurred (Figure 5.2). What was not appreciated, however, from this analysis 
is that significant atrophy occurred in the the EDL fast twitch fibers (~40-60%).  Had the 
mitochondrial reticulum remained intact throughout this process a proportional increase in 
SDH activity (and therefore staining) would have been expected. That this did not happen 
provides direct evidence that mitochondrial absorption/impaired oxidative capacity occurred 
consequent to diabetes. It is quite likely that this process was associated with functional 
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damage to the mitochondrial Ca2+ buffer capacity: although this hypothesis remains to be 
tested. 
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5.5 Summary 
 
This chapter demonstrates the first in vivo imaging of [Ca2+]i dynamics in skeletal muscle 
of diabetic rats is muscle fiber type specific. The principal original findings include the 
following. 1) In diabetes, compromised Ca2+ buffering and elevated [Ca2+]i following an in vivo 
fatiguing tetanic contraction occur preferentially in the fast twitch EDL rather than the slow 
twitch SOL muscle. 2) This process is associated with a substantial reduction in microvascular 
oxygen pressure that may be responsible, in part, for the dysfunctional Ca2+ buffering and 
greater fatigue. If dysfunction of SERCA1 and SERCA2 does occur it is likely to be oxygen 
related as their protein levels are up- and not down-regulated. Because the EDL muscle fibers 
undergo significant diabetes-induced atrophy it is also possible that the mitochondrial 
reticulum undergoes damage and its capacity to buffer [Ca2+]i is degraded. That eventuality 
remains to be experimentally tested.  
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Chapter 6 
Discussion 
 
6.1 Discussion 
 
In diabetes mellitus, there is a failure to maintain healthy muscle termed diabetic 
myopathy. Not only is muscle mass decreased but the muscle fibers are more fragile and 
fatigable and display abnormal [Ca2+]i regulation (i.e., impaired homeostasis). In particular, 
previous studies demonstrated that the [Ca2+]i dysregulation of diabetic muscle occurs in the 
presence of an enhanced SR function, at lease in vitro condition (i.e., extraction, tissue culture 
cell and homogenate). To date, the dysregulation of [Ca2+]i and SR function in diabetes has 
been investigated predominantly in vitro where, by necessity, the circulation is not intact. 
Thus, these muscles/muscle fibers are subjected to non-physiologic oxygen conditions 
including hyperoxia. However, in the original approach to the problem, Sonobe et al. 
demonstrated that the resting level of [Ca2+]i is increased after tetanic contractions in the in 
vivo (i.e., circulation intact) muscle preparation model. The muscle preparation model is 
spinotrapezius muscle that be characterized by an excellent candidate for intravital 
microscopy studies. Thus, the present study using the technique with an in vivo skeletal 
muscle model (anesthetized rat spinotrapezius), demonstrated a substantial degree of 
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impairment in Ca2+ regulation in diabetes. 
In the Chapter 2, the present investigation demonstrated that elevation of [Ca2+]i 
following repeated tetanic contraction in diabetic skeletal muscle, under in vivo condition. In 
the present investigation, Ca2+-activated neutral proteases (calpains) levels was not 
measured. However, it is also known that elevated [Ca2+]i activates calpains and may, 
therefore, be involved in the chronic morphological changes characteristic and the decline of 
the muscle contractile function in diabetes. 
In the Chapter 3, the present study using the originality-technique as microinjection, 
examined that Ca2+ release and uptake dynamics in vivo in individual spinotrapezius 
myocytes following Ca2+ injection. In the result, the present study demonstrated that Ca2+ 
release and uptake (significantly decreased peak [Ca2+]i and the buffering of [Ca2+]i following 
Ca2+ injection) dynamics in vivo in diabetic skeletal muscle is impaired. Therefore, it may be 
that impairment of [Ca2+]i homeostasis in diabetic skeletal muscle is attributable to the 
elevation of [Ca2+]i following repeated tetanic contraction (experimental result of Chapter 2). 
In the Chapter 4, the present investigation examined that morphological properties and 
SR Ca2+ regulatory proteins expression and mitochondrial oxidative enzyme activity in 
spinotrapezius muscles in diabetic rats. RyR content was decreased ～50% in spinotrapezius 
muscles from diabetes compared with healthy rats. The present study reveal that diabetic 
rats significantly decreased peak [Ca2+]i following Ca2+ injection (experimental result of 
Chapter 3). Correspondingly, attenuation of the Ca2+ release response in diabetes was 
accompanied by reduction of RyR protein level in the spinotrapezius muscle. On the other 
hand, interestingly, SR Ca2+-ATPase protein levels were not significantly different in 
spinotrapezius muscle in diabetic versus healthy rats.  
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Chapter 5 is the first in vivo imaging of [Ca2+]i dynamics study that examined the 
specificity of the muscle fiber type. Muscle composed mainly of fast-twitch, type II fibres (i.e., 
EDL) occurs elevation of [Ca2+]i following tetanic contraction, whereas muscle composed 
mainly of slow-twitch, type I fibres (i.e., SOL) were delay in the buffering of [Ca2+]i in diabetes 
compared with healthy rats. Thus, this study demonstrated that impairment depended on the 
muscle fiber type in diabetic skeletal muscle, and the influence appears in the fast twitch 
fiber rather than slow twitch fiber.  
Based on this thesis, the present investigation was performed using adult STZ induced 
diabetic animals. Hawke and colleagues demonstrated that direct action of STZ (i.e., 
independent of hyperglycemia) evokes changes in muscle fiber growth (Johnston et al., 2007) 
and muscle twitch characteristics (Krause et al., 2009). In particular, they suggested the 
possibility that STZ directly influences Ca2+ handling, such that it will be important to study 
alternative models of Type 1 diabetes mellitus to clarify the relationship between the 
hyperglycemic state and Ca2+ handling. 
In the thesis, mitochondrial Ca2+ level were not measured. Mitochondria play a crucial 
role in the buffering of [Ca2+]i for maintaining physiological Ca2+ regulation. Skeletal muscle 
is extensive evidence of mitochondrial Ca2+ handling (Bruton et al., 2003; Bolanos et al., 2008; 
Rossi et al., 2011; Scorzeto et al., 2013) and this seems to be linked to Ca2+ release from the SR 
through RyR which promotes Ca2+ uptake into neighboring mitochondria (Csordas et al., 
2006; Yi et al., 2012). Therefore, future experiments designed to that clarify the relationship 
between the hyperglycemic state and mitochondrial Ca2+ uptake in skeletal muscle. 
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